<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2020-10-07" version="259">
<accession>P02545</accession>
<accession>B4DI32</accession>
<accession>D3DVB0</accession>
<accession>D6RAQ3</accession>
<accession>E7EUI9</accession>
<accession>P02546</accession>
<accession>Q5I6Y4</accession>
<accession>Q5I6Y6</accession>
<accession>Q5TCJ2</accession>
<accession>Q5TCJ3</accession>
<accession>Q6UYC3</accession>
<accession>Q969I8</accession>
<accession>Q96JA2</accession>
<name>LMNA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Prelamin-A/C</fullName>
</recommendedName>
<component>
<recommendedName>
<fullName>Lamin-A/C</fullName>
</recommendedName>
<alternativeName>
<fullName>70 kDa lamin</fullName>
</alternativeName>
<alternativeName>
<fullName>Renal carcinoma antigen NY-REN-32</fullName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">LMNA</name>
<name type="synonym">LMN1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Nature" volume="319" first="463" last="468">
<title>Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins.</title>
<authorList>
<person name="McKeon F.D."/>
<person name="Kirschner M.W."/>
<person name="Caput D."/>
</authorList>
<dbReference type="PubMed" id="3453101"/>
<dbReference type="DOI" id="10.1038/319463a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND C)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="6450" last="6454">
<title>cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins.</title>
<authorList>
<person name="Fisher D.Z."/>
<person name="Chaudhary N."/>
<person name="Blobel G."/>
</authorList>
<dbReference type="PubMed" id="3462705"/>
<dbReference type="DOI" id="10.1073/pnas.83.17.6450"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND C)</scope>
<scope>PROTEIN SEQUENCE OF 583-644</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="J. Med. Genet." volume="42" first="639" last="647">
<title>In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.</title>
<authorList>
<person name="Sylvius N."/>
<person name="Bilinska Z.T."/>
<person name="Veinot J.P."/>
<person name="Fidzianska A."/>
<person name="Bolongo P.M."/>
<person name="Poon S."/>
<person name="McKeown P."/>
<person name="Davies R.A."/>
<person name="Chan K.-L."/>
<person name="Tang A.S.L."/>
<person name="Dyack S."/>
<person name="Grzybowski J."/>
<person name="Ruzyllo W."/>
<person name="McBride H."/>
<person name="Tesson F."/>
</authorList>
<dbReference type="PubMed" id="16061563"/>
<dbReference type="DOI" id="10.1136/jmg.2004.023283"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM C)</scope>
<scope>VARIANTS CMD1A TRP-190; GLY-192 AND SER-541</scope>
<scope>CHARACTERIZATION OF VARIANTS CMD1A GLY-192 AND SER-541</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-07" db="EMBL/GenBank/DDBJ databases">
<title>The progerin allele of lamin A disrupts chromatin organization.</title>
<authorList>
<person name="Csoka A.B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Corpus callosum</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS A AND C)</scope>
<source>
<tissue>Kidney</tissue>
<tissue>Lung</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2009-10" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Lilla S."/>
<person name="von Kriegsheim A."/>
<person name="Lempens A."/>
<person name="Kolch W."/>
<person name="Norman J.C."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 12-25; 29-90; 102-117; 120-166; 172-189; 197-216; 226-233; 241-260; 281-316; 320-329; 352-386; 440-453; 456-482; 472-482; 516-542; 585-624 AND 628-644</scope>
<scope>PHOSPHORYLATION AT SER-22</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Ovarian carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="9249" last="9253">
<title>An alternative splicing product of the lamin A/C gene lacks exon 10.</title>
<authorList>
<person name="Machiels B.M."/>
<person name="Zorenc A.H."/>
<person name="Endert J.M."/>
<person name="Kuijpers H.J."/>
<person name="van Eys G.J."/>
<person name="Ramaekers F.C."/>
<person name="Broers J.L."/>
</authorList>
<dbReference type="PubMed" id="8621584"/>
<dbReference type="DOI" id="10.1074/jbc.271.16.9249"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 375-664 (ISOFORM ADELTA10)</scope>
<source>
<tissue>Colon</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="J. Cell Sci." volume="107" first="61" last="67">
<title>The processing pathway of prelamin A.</title>
<authorList>
<person name="Sinensky M."/>
<person name="Fantle K."/>
<person name="Trujillo M."/>
<person name="McLain T."/>
<person name="Kupfer A."/>
<person name="Dalton M."/>
</authorList>
<dbReference type="PubMed" id="8175923"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE</scope>
<scope>ISOPRENYLATION AT CYS-661</scope>
<scope>METHYLATION AT CYS-661</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="5298" last="5304">
<title>In vitro assay and characterization of the farnesylation-dependent prelamin A endoprotease.</title>
<authorList>
<person name="Kilic F."/>
<person name="Dalton M.B."/>
<person name="Burrell S.K."/>
<person name="Mayer J.P."/>
<person name="Patterson S.D."/>
<person name="Sinensky M."/>
</authorList>
<dbReference type="PubMed" id="9030603"/>
<dbReference type="DOI" id="10.1074/jbc.272.8.5298"/>
</citation>
<scope>PROTEOLYTIC CLEAVAGE</scope>
<scope>ISOPRENYLATION AT CYS-661</scope>
<scope>METHYLATION AT CYS-661</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Int. J. Cancer" volume="83" first="456" last="464">
<title>Antigens recognized by autologous antibody in patients with renal-cell carcinoma.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gordan J.D."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Bander N.H."/>
<person name="Jongeneel C.V."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Jaeger E."/>
<person name="Knuth A."/>
<person name="Chen Y.-T."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="10508479"/>
<dbReference type="DOI" id="10.1002/(sici)1097-0215(19991112)83:4&lt;456::aid-ijc4&gt;3.0.co;2-5"/>
</citation>
<scope>IDENTIFICATION AS A RENAL CANCER ANTIGEN</scope>
<source>
<tissue>Renal cell carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="30008" last="30018">
<title>Prenylated prelamin A interacts with Narf, a novel nuclear protein.</title>
<authorList>
<person name="Barton R.M."/>
<person name="Worman H.J."/>
</authorList>
<dbReference type="PubMed" id="10514485"/>
<dbReference type="DOI" id="10.1074/jbc.274.42.30008"/>
</citation>
<scope>INTERACTION WITH NARF</scope>
<scope>MUTAGENESIS OF CYS-661</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="4401" last="4413">
<title>Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein.</title>
<authorList>
<person name="Markiewicz E."/>
<person name="Dechat T."/>
<person name="Foisner R."/>
<person name="Quinlan R.A."/>
<person name="Hutchison C.J."/>
</authorList>
<dbReference type="PubMed" id="12475961"/>
<dbReference type="DOI" id="10.1091/mbc.e02-07-0450"/>
</citation>
<scope>INTERACTION WITH TMPO-ALPHA AND RB1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Nature" volume="423" first="293" last="298">
<title>Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.</title>
<authorList>
<person name="Eriksson M."/>
<person name="Brown W.T."/>
<person name="Gordon L.B."/>
<person name="Glynn M.W."/>
<person name="Singer J."/>
<person name="Scott L."/>
<person name="Erdos M.R."/>
<person name="Robbins C.M."/>
<person name="Moses T.Y."/>
<person name="Berglund P."/>
<person name="Dutra A."/>
<person name="Pak E."/>
<person name="Durkin S."/>
<person name="Csoka A.B."/>
<person name="Boehnke M."/>
<person name="Glover T.W."/>
<person name="Collins F.S."/>
</authorList>
<dbReference type="PubMed" id="12714972"/>
<dbReference type="DOI" id="10.1038/nature01629"/>
</citation>
<scope>ALTERNATIVE SPLICING</scope>
<scope>INVOLVEMENT IN HGPS (ISOFORM 6)</scope>
<scope>VARIANTS HGPS LYS-145 AND SER-608</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-22; SER-390; SER-392; SER-395; SER-628; SER-632 AND SER-636</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-628</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Cell Biol." volume="182" first="35" last="39">
<title>Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies.</title>
<authorList>
<person name="Zhang Y.Q."/>
<person name="Sarge K.D."/>
</authorList>
<dbReference type="PubMed" id="18606848"/>
<dbReference type="DOI" id="10.1083/jcb.200712124"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUMOYLATION AT LYS-201</scope>
<scope>MUTAGENESIS OF LYS-201</scope>
<scope>CHARACTERIZATION OF VARIANTS CMD1A GLY-203 AND LYS-203</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-628</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-632</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; SER-18; THR-19; SER-22; SER-301; SER-390; SER-392; SER-395; SER-458; SER-628; SER-632; SER-636 AND SER-652</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Biol. Cell" volume="101" first="541" last="554">
<title>Emerin-prelamin A interplay in human fibroblasts.</title>
<authorList>
<person name="Capanni C."/>
<person name="Del Coco R."/>
<person name="Mattioli E."/>
<person name="Camozzi D."/>
<person name="Columbaro M."/>
<person name="Schena E."/>
<person name="Merlini L."/>
<person name="Squarzoni S."/>
<person name="Maraldi N.M."/>
<person name="Lattanzi G."/>
</authorList>
<dbReference type="PubMed" id="19323649"/>
<dbReference type="DOI" id="10.1042/bc20080175"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH EMD</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="J. Cell. Mol. Med." volume="13" first="959" last="971">
<title>The R439C mutation in LMNA causes lamin oligomerization and susceptibility to oxidative stress.</title>
<authorList>
<person name="Verstraeten V.L."/>
<person name="Caputo S."/>
<person name="van Steensel M.A."/>
<person name="Duband-Goulet I."/>
<person name="Zinn-Justin S."/>
<person name="Kamps M."/>
<person name="Kuijpers H.J."/>
<person name="Ostlund C."/>
<person name="Worman H.J."/>
<person name="Briede J.J."/>
<person name="Le Dour C."/>
<person name="Marcelis C.L."/>
<person name="van Geel M."/>
<person name="Steijlen P.M."/>
<person name="van den Wijngaard A."/>
<person name="Ramaekers F.C."/>
<person name="Broers J.L."/>
</authorList>
<dbReference type="PubMed" id="19220582"/>
<dbReference type="DOI" id="10.1111/j.1582-4934.2009.00690.x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS FPLD2 CYS-439 AND TRP-482</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-108; LYS-270; LYS-311 AND LYS-450</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Biochim. Biophys. Acta" volume="1800" first="448" last="458">
<title>Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins.</title>
<authorList>
<person name="De Vos W.H."/>
<person name="Houben F."/>
<person name="Hoebe R.A."/>
<person name="Hennekam R."/>
<person name="van Engelen B."/>
<person name="Manders E.M."/>
<person name="Ramaekers F.C."/>
<person name="Broers J.L."/>
<person name="Van Oostveldt P."/>
</authorList>
<dbReference type="PubMed" id="20079404"/>
<dbReference type="DOI" id="10.1016/j.bbagen.2010.01.002"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Circ. Cardiovasc. Genet." volume="3" first="6" last="14">
<title>Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.</title>
<authorList>
<person name="Cowan J."/>
<person name="Li D."/>
<person name="Gonzalez-Quintana J."/>
<person name="Morales A."/>
<person name="Hershberger R.E."/>
</authorList>
<dbReference type="PubMed" id="20160190"/>
<dbReference type="DOI" id="10.1161/circgenetics.109.905422"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANTS CMD1A LEU-89; PRO-101; PRO-166; GLN-190; LYS-203; SER-210; PRO-215; THR-318; HIS-388; CYS-399 AND HIS-471</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="Circulation" volume="121" first="2200" last="2210">
<title>Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging.</title>
<authorList>
<person name="Ragnauth C.D."/>
<person name="Warren D.T."/>
<person name="Liu Y."/>
<person name="McNair R."/>
<person name="Tajsic T."/>
<person name="Figg N."/>
<person name="Shroff R."/>
<person name="Skepper J."/>
<person name="Shanahan C.M."/>
</authorList>
<dbReference type="PubMed" id="20458013"/>
<dbReference type="DOI" id="10.1161/circulationaha.109.902056"/>
</citation>
<scope>FUNCTION</scope>
<scope>PROTEOLYTIC PROCESSING</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="3487" last="3498">
<title>Mammalian SUN protein interaction networks at the inner nuclear membrane and their role in laminopathy disease processes.</title>
<authorList>
<person name="Haque F."/>
<person name="Mazzeo D."/>
<person name="Patel J.T."/>
<person name="Smallwood D.T."/>
<person name="Ellis J.A."/>
<person name="Shanahan C.M."/>
<person name="Shackleton S."/>
</authorList>
<dbReference type="PubMed" id="19933576"/>
<dbReference type="DOI" id="10.1074/jbc.m109.071910"/>
</citation>
<scope>INTERACTION WITH SUN1</scope>
<scope>CHARACTERIZATION OF VARIANTS EDMD2 PRO-527 AND PRO-530</scope>
<scope>CHARACTERIZATION OF VARIANT HGPS SER-608</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; SER-12; THR-19; SER-22; SER-212; SER-277; SER-301; SER-390; SER-392; SER-395; SER-404; SER-414; SER-431; SER-458; SER-463; THR-505; SER-628; SER-632; SER-636 AND SER-652</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="19702" last="19713">
<title>Identification of a novel muscle enriched A-type Lamin interacting protein (MLIP).</title>
<authorList>
<person name="Ahmady E."/>
<person name="Deeke S.A."/>
<person name="Rabaa S."/>
<person name="Kouri L."/>
<person name="Kenney L."/>
<person name="Stewart A.F."/>
<person name="Burgon P.G."/>
</authorList>
<dbReference type="PubMed" id="21498514"/>
<dbReference type="DOI" id="10.1074/jbc.m110.165548"/>
</citation>
<scope>INTERACTION WITH MLIP</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-390; SER-392; SER-404; SER-414; SER-458 AND SER-636</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E32120" last="E32120">
<title>Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.</title>
<authorList>
<person name="Barrowman J."/>
<person name="Hamblet C."/>
<person name="Kane M.S."/>
<person name="Michaelis S."/>
</authorList>
<dbReference type="PubMed" id="22355414"/>
<dbReference type="DOI" id="10.1371/journal.pone.0032120"/>
</citation>
<scope>MUTAGENESIS OF ARG-644; LEU-647; LEU-648; ASN-650 AND CYS-661</scope>
<scope>CHARACTERIZATION OF VARIANT HGPS CYS-644</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="Am. J. Med. Genet. A" volume="161" first="1599" last="1611">
<title>LMNA-associated cardiocutaneous progeria: An inherited autosomal dominant premature aging syndrome with late onset.</title>
<authorList>
<person name="Kane M.S."/>
<person name="Lindsay M.E."/>
<person name="Judge D.P."/>
<person name="Barrowman J."/>
<person name="Ap Rhys C."/>
<person name="Simonson L."/>
<person name="Dietz H.C."/>
<person name="Michaelis S."/>
</authorList>
<dbReference type="PubMed" id="23666920"/>
<dbReference type="DOI" id="10.1002/ajmg.a.35971"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INVOLVEMENT IN HGPS</scope>
<scope>VARIANT HGPS GLY-300</scope>
<scope>CHARACTERIZATION OF VARIANT HGPS GLY-300</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; THR-19; SER-22; SER-51; SER-66; SER-71; SER-107; SER-212; SER-301; SER-390; SER-392; SER-398; SER-429; SER-458; SER-463; SER-533; SER-613; SER-619; SER-628; SER-632 AND SER-636</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2013" name="Nat. Commun." volume="4" first="1868" last="1868">
<title>Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model.</title>
<authorList>
<person name="Liu B."/>
<person name="Wang Z."/>
<person name="Zhang L."/>
<person name="Ghosh S."/>
<person name="Zheng H."/>
<person name="Zhou Z."/>
</authorList>
<dbReference type="PubMed" id="23695662"/>
<dbReference type="DOI" id="10.1038/ncomms2885"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH SUV39H1</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="40296" last="40306">
<title>Myotonic dystrophy protein kinase is critical for nuclear envelope integrity.</title>
<authorList>
<person name="Harmon E.B."/>
<person name="Harmon M.L."/>
<person name="Larsen T.D."/>
<person name="Yang J."/>
<person name="Glasford J.W."/>
<person name="Perryman M.B."/>
</authorList>
<dbReference type="PubMed" id="21949239"/>
<dbReference type="DOI" id="10.1074/jbc.m111.241455"/>
</citation>
<scope>INTERACTION WITH DMPK</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12; THR-19; SER-22; SER-212; SER-301; SER-307; SER-390; SER-395; SER-403; SER-404; SER-414; SER-458; SER-463; SER-612 AND SER-636</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-97; LYS-208; LYS-233; LYS-311; LYS-378; LYS-417 AND LYS-420</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-233 AND LYS-597</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-97; LYS-311; LYS-378 AND LYS-420</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-233; LYS-260; LYS-270; LYS-378; LYS-417 AND LYS-420</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-97; LYS-171; LYS-201; LYS-208; LYS-219; LYS-233; LYS-260; LYS-270; LYS-311; LYS-366; LYS-378; LYS-417; LYS-420; LYS-450; LYS-470; LYS-486 AND LYS-597</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2018" name="Biochem. J." volume="475" first="1455" last="1472">
<title>Intersectin goes nuclear: secret life of an endocytic protein.</title>
<authorList>
<person name="Alvisi G."/>
<person name="Paolini L."/>
<person name="Contarini A."/>
<person name="Zambarda C."/>
<person name="Di Antonio V."/>
<person name="Colosini A."/>
<person name="Mercandelli N."/>
<person name="Timmoneri M."/>
<person name="Palu G."/>
<person name="Caimi L."/>
<person name="Ricotta D."/>
<person name="Radeghieri A."/>
</authorList>
<dbReference type="PubMed" id="29599122"/>
<dbReference type="DOI" id="10.1042/bcj20170897"/>
</citation>
<scope>INTERACTION WITH ITSN1 ISOFORM 2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="17381" last="17384">
<title>Structure of the globular tail of nuclear lamin.</title>
<authorList>
<person name="Dhe-Paganon S."/>
<person name="Werner E.D."/>
<person name="Chi Y.I."/>
<person name="Shoelson S.E."/>
</authorList>
<dbReference type="PubMed" id="11901143"/>
<dbReference type="DOI" id="10.1074/jbc.c200038200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 435-552</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2002" name="Structure" volume="10" first="811" last="823">
<title>The Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular dystrophies, cardiomyopathy, and partial lipodystrophy.</title>
<authorList>
<person name="Krimm I."/>
<person name="Ostlund C."/>
<person name="Gilquin B."/>
<person name="Couprie J."/>
<person name="Hossenlopp P."/>
<person name="Mornon J.-P."/>
<person name="Bonne G."/>
<person name="Courvalin J.-C."/>
<person name="Worman H.J."/>
<person name="Zinn-Justin S."/>
</authorList>
<dbReference type="PubMed" id="12057196"/>
<dbReference type="DOI" id="10.1016/s0969-2126(02)00777-3"/>
</citation>
<scope>STRUCTURE BY NMR OF 428-549</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2004" name="J. Mol. Biol." volume="343" first="1067" last="1080">
<title>Crystal structure of the human lamin A coil 2B dimer: implications for the head-to-tail association of nuclear lamins.</title>
<authorList>
<person name="Strelkov S.V."/>
<person name="Schumacher J."/>
<person name="Burkhard P."/>
<person name="Aebi U."/>
<person name="Herrmann H."/>
</authorList>
<dbReference type="PubMed" id="15476822"/>
<dbReference type="DOI" id="10.1016/j.jmb.2004.08.093"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 305-387</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1999" name="Nat. Genet." volume="21" first="285" last="288">
<title>Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.</title>
<authorList>
<person name="Bonne G."/>
<person name="Di Barletta M.R."/>
<person name="Varnous S."/>
<person name="Becane H.-M."/>
<person name="Hammouda E.-H."/>
<person name="Merlini L."/>
<person name="Muntoni F."/>
<person name="Greenberg C.R."/>
<person name="Gary F."/>
<person name="Urtizberea J.-A."/>
<person name="Duboc D."/>
<person name="Fardeau M."/>
<person name="Toniolo D."/>
<person name="Schwartz K."/>
</authorList>
<dbReference type="PubMed" id="10080180"/>
<dbReference type="DOI" id="10.1038/6799"/>
</citation>
<scope>VARIANTS EDMD2 TRP-453; PRO-527 AND PRO-530</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1999" name="N. Engl. J. Med." volume="341" first="1715" last="1724">
<title>Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.</title>
<authorList>
<person name="Fatkin D."/>
<person name="MacRae C."/>
<person name="Sasaki T."/>
<person name="Wolff M.R."/>
<person name="Porcu M."/>
<person name="Frenneaux M."/>
<person name="Atherton J."/>
<person name="Vidaillet H.J. Jr."/>
<person name="Spudich S."/>
<person name="De Girolami U."/>
<person name="Seidman J.G."/>
<person name="Seidman C.E."/>
</authorList>
<dbReference type="PubMed" id="10580070"/>
<dbReference type="DOI" id="10.1056/nejm199912023412302"/>
</citation>
<scope>VARIANTS CMD1A GLY-60; ARG-85; LYS-195 AND GLY-203</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="66" first="1192" last="1198">
<title>Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C.</title>
<authorList>
<person name="Speckman R.A."/>
<person name="Garg A."/>
<person name="Du F."/>
<person name="Bennett L."/>
<person name="Veile R."/>
<person name="Arioglu E."/>
<person name="Taylor S.I."/>
<person name="Lovett M."/>
<person name="Bowcock A.M."/>
</authorList>
<dbReference type="PubMed" id="10739751"/>
<dbReference type="DOI" id="10.1086/302836"/>
</citation>
<scope>VARIANTS FPLD2 ASP-465; GLN-482; TRP-482 AND HIS-582</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="67" first="775" last="775">
<authorList>
<person name="Speckman R.A."/>
<person name="Garg A."/>
<person name="Du F."/>
<person name="Bennett L."/>
<person name="Veile R."/>
<person name="Arioglu E."/>
<person name="Taylor S.I."/>
<person name="Lovett M."/>
<person name="Bowcock A.M."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:10739751</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2000" name="Am. J. Hum. Genet." volume="66" first="1407" last="1412">
<title>Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy.</title>
<authorList>
<person name="Raffaele di Barletta M."/>
<person name="Ricci E."/>
<person name="Galluzzi G."/>
<person name="Tonali P."/>
<person name="Mora M."/>
<person name="Morandi L."/>
<person name="Romorini A."/>
<person name="Voit T."/>
<person name="Orstavik K.H."/>
<person name="Merlini L."/>
<person name="Trevisan C."/>
<person name="Biancalana V."/>
<person name="Housmanowa-Petrusewicz I."/>
<person name="Bione S."/>
<person name="Ricotti R."/>
<person name="Schwartz K."/>
<person name="Bonne G."/>
<person name="Toniolo D."/>
</authorList>
<dbReference type="PubMed" id="10739764"/>
<dbReference type="DOI" id="10.1086/302869"/>
</citation>
<scope>VARIANTS EDMD2 TYR-222; GLN-249; GLN-336; TRP-453; THR-469; PRO-527 AND LYS-528</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2000" name="Ann. Neurol." volume="48" first="170" last="180">
<title>Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene.</title>
<authorList>
<person name="Bonne G."/>
<person name="Mercuri E."/>
<person name="Muchir A."/>
<person name="Urtizberea A."/>
<person name="Becane H.M."/>
<person name="Recan D."/>
<person name="Merlini L."/>
<person name="Wehnert M."/>
<person name="Boor R."/>
<person name="Reuner U."/>
<person name="Vorgerd M."/>
<person name="Wicklein E.M."/>
<person name="Eymard B."/>
<person name="Duboc D."/>
<person name="Penisson-Besnier I."/>
<person name="Cuisset J.M."/>
<person name="Ferrer X."/>
<person name="Desguerre I."/>
<person name="Lacombe D."/>
<person name="Bushby K."/>
<person name="Pollitt C."/>
<person name="Toniolo D."/>
<person name="Fardeau M."/>
<person name="Schwartz K."/>
<person name="Muntoni F."/>
</authorList>
<dbReference type="PubMed" id="10939567"/>
<dbReference type="DOI" id="10.1002/1531-8249(200008)48:2&lt;170::aid-ana6&gt;3.0.co;2-j"/>
</citation>
<scope>VARIANTS EDMD2 CYS-45; PRO-50; SER-63; GLU-112 DEL; PRO-222; GLU-232; GLN-249; LYS-261 DEL; PRO-294; LYS-358; LYS-371; LYS-386; TRP-453; LYS-456; SER-520; PRO-527 AND LYS-528</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2000" name="Hum. Mol. Genet." volume="9" first="109" last="112">
<title>Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy.</title>
<authorList>
<person name="Cao H."/>
<person name="Hegele R.A."/>
</authorList>
<dbReference type="PubMed" id="10587585"/>
<dbReference type="DOI" id="10.1093/hmg/9.1.109"/>
</citation>
<scope>VARIANT FPLD2 GLN-482</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2000" name="Hum. Mol. Genet." volume="9" first="1453" last="1459">
<title>Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).</title>
<authorList>
<person name="Muchir A."/>
<person name="Bonne G."/>
<person name="van der Kooi A.J."/>
<person name="van Meegen M."/>
<person name="Baas F."/>
<person name="Bolhuis P.A."/>
<person name="de Visser M."/>
<person name="Schwartz K."/>
</authorList>
<dbReference type="PubMed" id="10814726"/>
<dbReference type="DOI" id="10.1093/hmg/9.9.1453"/>
</citation>
<scope>VARIANTS EDMD2 LYS-208 DEL AND HIS-377</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2000" name="Nat. Genet." volume="24" first="153" last="156">
<title>LMNA, encoding lamin A/C, is mutated in partial lipodystrophy.</title>
<authorList>
<person name="Shackleton S."/>
<person name="Lloyd D.J."/>
<person name="Jackson S.N.J."/>
<person name="Evans R."/>
<person name="Niermeijer M.F."/>
<person name="Singh B.M."/>
<person name="Schmidt H."/>
<person name="Brabant G."/>
<person name="Kumar S."/>
<person name="Durrington P.N."/>
<person name="Gregory S."/>
<person name="O'Rahilly S."/>
<person name="Trembath R.C."/>
</authorList>
<dbReference type="PubMed" id="10655060"/>
<dbReference type="DOI" id="10.1038/72807"/>
</citation>
<scope>VARIANTS FPLD2 LEU-482 AND TRP-482</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2000" name="Neurology" volume="55" first="275" last="280">
<title>Autosomal dominant Emery-Dreifuss dystrophy due to mutations in rod domain of the lamin A/C gene.</title>
<authorList>
<person name="Felice K.J."/>
<person name="Schwartz R.C."/>
<person name="Brown C.A."/>
<person name="Leicher C.R."/>
<person name="Grunnet M.L."/>
</authorList>
<dbReference type="PubMed" id="10908904"/>
<dbReference type="DOI" id="10.1212/wnl.55.2.275"/>
</citation>
<scope>VARIANTS EDMD2 PRO-150 AND LYS-261 DEL</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2001" name="Am. J. Med. Genet." volume="102" first="359" last="367">
<title>Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy.</title>
<authorList>
<person name="Brown C.A."/>
<person name="Lanning R.W."/>
<person name="McKinney K.Q."/>
<person name="Salvino A.R."/>
<person name="Cherniske E."/>
<person name="Crowe C.A."/>
<person name="Darras B.T."/>
<person name="Gominak S."/>
<person name="Greenberg C.R."/>
<person name="Grosmann C."/>
<person name="Heydemann P."/>
<person name="Mendell J.R."/>
<person name="Pober B.R."/>
<person name="Sasaki T."/>
<person name="Shapiro F."/>
<person name="Simpson D.A."/>
<person name="Suchowersky O."/>
<person name="Spence J.E."/>
</authorList>
<dbReference type="PubMed" id="11503164"/>
<dbReference type="DOI" id="10.1002/ajmg.1463"/>
</citation>
<scope>VARIANTS EDMD2 PRO-25; THR-43; SER-50; PRO-133; 196-ARG--THR-199 DELINS SER; GLN-249; LYS-261 DEL; LYS-358; TRP-453; ILE-456; PRO-527 AND HIS-624</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2001" name="J. Card. Fail." volume="7" first="249" last="256">
<title>Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease.</title>
<authorList>
<person name="Jakobs P.M."/>
<person name="Hanson E.L."/>
<person name="Crispell K.A."/>
<person name="Toy W."/>
<person name="Keegan H."/>
<person name="Schilling K."/>
<person name="Icenogle T.B."/>
<person name="Litt M."/>
<person name="Hershberger R.E."/>
</authorList>
<dbReference type="PubMed" id="11561226"/>
<dbReference type="DOI" id="10.1054/jcaf.2001.26339"/>
</citation>
<scope>VARIANT CMD1A LYS-203</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2001" name="J. Cell Sci." volume="114" first="4435" last="4445">
<title>Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy.</title>
<authorList>
<person name="Oestlund C."/>
<person name="Bonne G."/>
<person name="Schwartz K."/>
<person name="Worman H.J."/>
</authorList>
<dbReference type="PubMed" id="11792809"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS CMD1A GLY-60; ARG-85; LYS-195 AND GLY-203</scope>
<scope>CHARACTERIZATION OF VARIANTS EDMD2 LYS-358; LYS-371; LYS-386; TRP-453; SER-520; PRO-527; LYS-528 AND PRO-530</scope>
<scope>CHARACTERIZATION OF VARIANTS FPLD2 GLN-482; TRP-482 AND ASN-486</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2001" name="Neuromuscul. Disord." volume="11" first="542" last="546">
<title>A missense mutation in the exon 8 of lamin A/C gene in a Japanese case of autosomal dominant limb-girdle muscular dystrophy and cardiac conduction block.</title>
<authorList>
<person name="Kitaguchi T."/>
<person name="Matsubara S."/>
<person name="Sato M."/>
<person name="Miyamoto K."/>
<person name="Hirai S."/>
<person name="Schwartz K."/>
<person name="Bonne G."/>
</authorList>
<dbReference type="PubMed" id="11525883"/>
<dbReference type="DOI" id="10.1016/s0960-8966(01)00207-3"/>
</citation>
<scope>VARIANT EDMD2 HIS-481</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2002" name="Am. Heart J." volume="144" first="1081" last="1086">
<title>A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation.</title>
<authorList>
<person name="Hershberger R.E."/>
<person name="Hanson E.L."/>
<person name="Jakobs P.M."/>
<person name="Keegan H."/>
<person name="Coates K."/>
<person name="Bousman S."/>
<person name="Litt M."/>
</authorList>
<dbReference type="PubMed" id="12486434"/>
<dbReference type="DOI" id="10.1067/mhj.2002.126737"/>
</citation>
<scope>VARIANT CMD1A PRO-215</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="70" first="726" last="736">
<title>Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse.</title>
<authorList>
<person name="De Sandre-Giovannoli A."/>
<person name="Chaouch M."/>
<person name="Kozlov S."/>
<person name="Vallat J.-M."/>
<person name="Tazir M."/>
<person name="Kassouri N."/>
<person name="Szepetowski P."/>
<person name="Hammadouche T."/>
<person name="Vandenberghe A."/>
<person name="Stewart C.L."/>
<person name="Grid D."/>
<person name="Levy N."/>
</authorList>
<dbReference type="PubMed" id="11799477"/>
<dbReference type="DOI" id="10.1086/339274"/>
</citation>
<scope>VARIANT CMT2B1 CYS-298</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="70" first="1075" last="1075">
<authorList>
<person name="De Sandre-Giovannoli A."/>
<person name="Chaouch M."/>
<person name="Kozlov S."/>
<person name="Vallat J.-M."/>
<person name="Tazir M."/>
<person name="Kassouri N."/>
<person name="Szepetowski P."/>
<person name="Hammadouche T."/>
<person name="Vandenberghe A."/>
<person name="Stewart C.L."/>
<person name="Grid D."/>
<person name="Levy N."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:11799477</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="71" first="426" last="431">
<title>Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C.</title>
<authorList>
<person name="Novelli G."/>
<person name="Muchir A."/>
<person name="Sangiuolo F."/>
<person name="Helbling-Leclerc A."/>
<person name="D'Apice M.R."/>
<person name="Massart C."/>
<person name="Capon F."/>
<person name="Sbraccia P."/>
<person name="Federici M."/>
<person name="Lauro R."/>
<person name="Tudisco C."/>
<person name="Pallotta R."/>
<person name="Scarano G."/>
<person name="Dallapiccola B."/>
<person name="Merlini L."/>
<person name="Bonne G."/>
</authorList>
<dbReference type="PubMed" id="12075506"/>
<dbReference type="DOI" id="10.1086/341908"/>
</citation>
<scope>VARIANT MADA HIS-527</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2002" name="Am. J. Med." volume="112" first="549" last="555">
<title>Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene.</title>
<authorList>
<person name="Garg A."/>
<person name="Speckman R.A."/>
<person name="Bowcock A.M."/>
</authorList>
<dbReference type="PubMed" id="12015247"/>
<dbReference type="DOI" id="10.1016/s0002-9343(02)01070-7"/>
</citation>
<scope>VARIANTS FPLD2 TRP-28 AND GLY-62</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2002" name="J. Am. Coll. Cardiol." volume="39" first="981" last="990">
<title>Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.</title>
<authorList>
<person name="Arbustini E."/>
<person name="Pilotto A."/>
<person name="Repetto A."/>
<person name="Grasso M."/>
<person name="Negri A."/>
<person name="Diegoli M."/>
<person name="Campana C."/>
<person name="Scelsi L."/>
<person name="Baldini E."/>
<person name="Gavazzi A."/>
<person name="Tavazzi L."/>
</authorList>
<dbReference type="PubMed" id="11897440"/>
<dbReference type="DOI" id="10.1016/s0735-1097(02)01724-2"/>
</citation>
<scope>VARIANTS CMD1A GLU-97; TRP-190 AND LYS-317</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2002" name="J. Hum. Genet." volume="47" first="225" last="228">
<title>Identification of lamin A/C (LMNA) gene mutations in Korean patients with autosomal dominant Emery-Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B.</title>
<authorList>
<person name="Ki C.-S."/>
<person name="Hong J.S."/>
<person name="Jeong G.-Y."/>
<person name="Ahn K.J."/>
<person name="Choi K.-M."/>
<person name="Kim D.-K."/>
<person name="Kim J.-W."/>
</authorList>
<dbReference type="PubMed" id="12032588"/>
<dbReference type="DOI" id="10.1007/s100380200029"/>
</citation>
<scope>VARIANT EDMD2 GLN-249</scope>
<scope>VARIANT EDMD2 LEU-377</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2002" name="Neurology" volume="59" first="620" last="623">
<title>Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy.</title>
<authorList>
<person name="van der Kooi A.J."/>
<person name="Bonne G."/>
<person name="Eymard B."/>
<person name="Duboc D."/>
<person name="Talim B."/>
<person name="Van der Valk M."/>
<person name="Reiss P."/>
<person name="Richard P."/>
<person name="Demay L."/>
<person name="Merlini L."/>
<person name="Schwartz K."/>
<person name="Busch H.F.M."/>
<person name="de Visser M."/>
</authorList>
<dbReference type="PubMed" id="12196663"/>
<dbReference type="DOI" id="10.1212/wnl.59.4.620"/>
</citation>
<scope>VARIANTS FPLD2 GLY-60 AND PRO-527</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2002" name="Neuromuscul. Disord." volume="12" first="958" last="963">
<title>Frequent low penetrance mutations in the Lamin A/C gene, causing Emery Dreifuss muscular dystrophy.</title>
<authorList>
<person name="Vytopil M."/>
<person name="Ricci E."/>
<person name="Dello Russo A."/>
<person name="Hanisch F."/>
<person name="Neudecker S."/>
<person name="Zierz S."/>
<person name="Ricotti R."/>
<person name="Demay L."/>
<person name="Richard P."/>
<person name="Wehnert M."/>
<person name="Bonne G."/>
<person name="Merlini L."/>
<person name="Toniolo D."/>
</authorList>
<dbReference type="PubMed" id="12467752"/>
<dbReference type="DOI" id="10.1016/s0960-8966(02)00178-5"/>
</citation>
<scope>VARIANTS EDMD2 LYS-32 DEL; ASN-63; GLN-336; GLN-343 AND CYS-401</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2003" name="Eur. J. Heart Fail." volume="5" first="821" last="825">
<title>Apical left ventricular aneurysm without atrio-ventricular block due to a lamin A/C gene mutation.</title>
<authorList>
<person name="Forissier J.-F."/>
<person name="Bonne G."/>
<person name="Bouchier C."/>
<person name="Duboscq-Bidot L."/>
<person name="Richard P."/>
<person name="Wisnewski C."/>
<person name="Briault S."/>
<person name="Moraine C."/>
<person name="Dubourg O."/>
<person name="Schwartz K."/>
<person name="Komajda M."/>
</authorList>
<dbReference type="PubMed" id="14675861"/>
<dbReference type="DOI" id="10.1016/s1388-9842(03)00149-1"/>
</citation>
<scope>VARIANT CMD1A CYS-541</scope>
</reference>
<reference key="76">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="21" first="473" last="481">
<title>Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.</title>
<authorList>
<person name="Charniot J.-C."/>
<person name="Pascal C."/>
<person name="Bouchier C."/>
<person name="Sebillon P."/>
<person name="Salama J."/>
<person name="Duboscq-Bidot L."/>
<person name="Peuchmaurd M."/>
<person name="Desnos M."/>
<person name="Artigou J.-Y."/>
<person name="Komajda M."/>
</authorList>
<dbReference type="PubMed" id="12673789"/>
<dbReference type="DOI" id="10.1002/humu.10170"/>
</citation>
<scope>VARIANT EDMD2 HIS-377</scope>
</reference>
<reference key="77">
<citation type="journal article" date="2003" name="J. Am. Coll. Cardiol." volume="41" first="771" last="780">
<title>Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.</title>
<authorList>
<consortium name="Familial dilated cardiomyopathy registry research group"/>
<person name="Taylor M.R.G."/>
<person name="Fain P.R."/>
<person name="Sinagra G."/>
<person name="Robinson M.L."/>
<person name="Robertson A.D."/>
<person name="Carniel E."/>
<person name="Di Lenarda A."/>
<person name="Bohlmeyer T.J."/>
<person name="Ferguson D.A."/>
<person name="Brodsky G.L."/>
<person name="Boucek M.M."/>
<person name="Lascor J."/>
<person name="Moss A.C."/>
<person name="Li W.-L.P."/>
<person name="Stetler G.L."/>
<person name="Muntoni F."/>
<person name="Bristow M.R."/>
<person name="Mestroni L."/>
</authorList>
<dbReference type="PubMed" id="12628721"/>
<dbReference type="DOI" id="10.1016/s0735-1097(02)02954-6"/>
</citation>
<scope>VARIANTS CMD1A LEU-89; HIS-377 AND LEU-573</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2003" name="J. Am. Coll. Cardiol." volume="42" first="590" last="590">
<authorList>
<consortium name="Familial dilated cardiomyopathy registry research group"/>
<person name="Taylor M.R.G."/>
<person name="Fain P.R."/>
<person name="Sinagra G."/>
<person name="Robinson M.L."/>
<person name="Robertson A.D."/>
<person name="Carniel E."/>
<person name="Di Lenarda A."/>
<person name="Bohlmeyer T.J."/>
<person name="Ferguson D.A."/>
<person name="Brodsky G.L."/>
<person name="Boucek M.M."/>
<person name="Lascor J."/>
<person name="Moss A.C."/>
<person name="Li W.-L.P."/>
<person name="Stetler G.L."/>
<person name="Muntoni F."/>
<person name="Bristow M.R."/>
<person name="Mestroni L."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:12628721</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2003" name="J. Clin. Endocrinol. Metab." volume="88" first="1006" last="1013">
<title>A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy.</title>
<authorList>
<person name="Caux F."/>
<person name="Dubosclard E."/>
<person name="Lascols O."/>
<person name="Buendia B."/>
<person name="Chazouilleres O."/>
<person name="Cohen A."/>
<person name="Courvalin J.-C."/>
<person name="Laroche L."/>
<person name="Capeau J."/>
<person name="Vigouroux C."/>
<person name="Christin-Maitre S."/>
</authorList>
<dbReference type="PubMed" id="12629077"/>
<dbReference type="DOI" id="10.1210/jc.2002-021506"/>
</citation>
<scope>VARIANT FPLD2 LEU-133</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2003" name="J. Hum. Genet." volume="48" first="271" last="274">
<title>LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090).</title>
<authorList>
<person name="Cao H."/>
<person name="Hegele R.A."/>
</authorList>
<dbReference type="PubMed" id="12768443"/>
<dbReference type="DOI" id="10.1007/s10038-003-0025-3"/>
</citation>
<scope>VARIANTS HGPS CYS-471; CYS-527 AND SER-608</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2003" name="J. Med. Genet." volume="40" first="560" last="567">
<title>Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.</title>
<authorList>
<person name="Sebillon P."/>
<person name="Bouchier C."/>
<person name="Bidot L.D."/>
<person name="Bonne G."/>
<person name="Ahamed K."/>
<person name="Charron P."/>
<person name="Drouin-Garraud V."/>
<person name="Millaire A."/>
<person name="Desrumeaux G."/>
<person name="Benaiche A."/>
<person name="Charniot J.-C."/>
<person name="Schwartz K."/>
<person name="Villard E."/>
<person name="Komajda M."/>
</authorList>
<dbReference type="PubMed" id="12920062"/>
<dbReference type="DOI" id="10.1136/jmg.40.8.560"/>
</citation>
<scope>VARIANT CMD1A LYS-161</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2003" name="J. Med. Genet." volume="40" first="E132" last="E132">
<title>Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes.</title>
<authorList>
<person name="Vytopil M."/>
<person name="Benedetti S."/>
<person name="Ricci E."/>
<person name="Galluzzi G."/>
<person name="Dello Russo A."/>
<person name="Merlini L."/>
<person name="Boriani G."/>
<person name="Gallina M."/>
<person name="Morandi L."/>
<person name="Politano L."/>
<person name="Moggio M."/>
<person name="Chiveri L."/>
<person name="Hausmanova-Petrusewicz I."/>
<person name="Ricotti R."/>
<person name="Vohanka S."/>
<person name="Toman J."/>
<person name="Toniolo D."/>
</authorList>
<dbReference type="PubMed" id="14684700"/>
<dbReference type="DOI" id="10.1136/jmg.40.12.e132"/>
</citation>
<scope>VARIANTS EDMD2 GLY-25; LYS-32 DEL; VAL-35; GLY-65; GLU-112 DEL; PRO-248; GLN-249; CYS-267; VAL-446; TRP-453; ARG-528 AND HIS-541</scope>
<scope>VARIANT CMD1A CYS-435</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2003" name="Lancet" volume="362" first="440" last="445">
<title>LMNA mutations in atypical Werner's syndrome.</title>
<authorList>
<person name="Chen L."/>
<person name="Lee L."/>
<person name="Kudlow B.A."/>
<person name="Dos Santos H.G."/>
<person name="Sletvold O."/>
<person name="Shafeghati Y."/>
<person name="Botha E.G."/>
<person name="Garg A."/>
<person name="Hanson N.B."/>
<person name="Martin G.M."/>
<person name="Mian I.S."/>
<person name="Kennedy B.K."/>
<person name="Oshima J."/>
</authorList>
<dbReference type="PubMed" id="12927431"/>
<dbReference type="DOI" id="10.1016/s0140-6736(03)14069-x"/>
</citation>
<scope>VARIANT CMDHH PRO-57</scope>
<scope>VARIANT HGPS ARG-140</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2003" name="Stroke" volume="34" first="901" last="908">
<title>Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study.</title>
<authorList>
<person name="Boriani G."/>
<person name="Gallina M."/>
<person name="Merlini L."/>
<person name="Bonne G."/>
<person name="Toniolo D."/>
<person name="Amati S."/>
<person name="Biffi M."/>
<person name="Martignani C."/>
<person name="Frabetti L."/>
<person name="Bonvicini M."/>
<person name="Rapezzi C."/>
<person name="Branzi A."/>
</authorList>
<dbReference type="PubMed" id="12649505"/>
<dbReference type="DOI" id="10.1161/01.str.0000064322.47667.49"/>
</citation>
<scope>VARIANTS EDMD2 ASN-63; PRO-140; GLN-249; LEU-377; LYS-386 AND PRO-527</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2004" name="Am. J. Cardiol." volume="94" first="50" last="54">
<title>Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations.</title>
<authorList>
<person name="Hermida-Prieto M."/>
<person name="Monserrat L."/>
<person name="Castro-Beiras A."/>
<person name="Laredo R."/>
<person name="Soler R."/>
<person name="Peteiro J."/>
<person name="Rodriguez E."/>
<person name="Bouzas B."/>
<person name="Alvarez N."/>
<person name="Muniz J."/>
<person name="Crespo-Leiro M."/>
</authorList>
<dbReference type="PubMed" id="15219508"/>
<dbReference type="DOI" id="10.1016/j.amjcard.2004.03.029"/>
</citation>
<scope>VARIANTS CMD1A TRP-190 AND LEU-349</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2004" name="Eur. Heart J." volume="25" first="885" last="893">
<title>A novel mutation, Ser143Pro, in the lamin A/C gene is common in Finnish patients with familial dilated cardiomyopathy.</title>
<authorList>
<person name="Kaerkkaeinen S."/>
<person name="Helioe T."/>
<person name="Miettinen R."/>
<person name="Tuomainen P."/>
<person name="Peltola P."/>
<person name="Rummukainen J."/>
<person name="Ylitalo K."/>
<person name="Kaartinen M."/>
<person name="Kuusisto J."/>
<person name="Toivonen L."/>
<person name="Nieminen M.S."/>
<person name="Laakso M."/>
<person name="Peuhkurinen K."/>
</authorList>
<dbReference type="PubMed" id="15140538"/>
<dbReference type="DOI" id="10.1016/j.ehj.2004.01.020"/>
</citation>
<scope>VARIANT CMD1A PRO-143</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="2493" last="2503">
<title>Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy.</title>
<authorList>
<person name="Navarro C.L."/>
<person name="De Sandre-Giovannoli A."/>
<person name="Bernard R."/>
<person name="Boccaccio I."/>
<person name="Boyer A."/>
<person name="Genevieve D."/>
<person name="Hadj-Rabia S."/>
<person name="Gaudy-Marqueste C."/>
<person name="Smitt H.S."/>
<person name="Vabres P."/>
<person name="Faivre L."/>
<person name="Verloes A."/>
<person name="Van Essen T."/>
<person name="Flori E."/>
<person name="Hennekam R."/>
<person name="Beemer F.A."/>
<person name="Laurent N."/>
<person name="Le Merrer M."/>
<person name="Cau P."/>
<person name="Levy N."/>
</authorList>
<dbReference type="PubMed" id="15317753"/>
<dbReference type="DOI" id="10.1093/hmg/ddh265"/>
</citation>
<scope>INVOLVEMENT IN LTSCS</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2004" name="J. Med. Genet." volume="41" first="304" last="308">
<title>Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes.</title>
<authorList>
<person name="Csoka A.B."/>
<person name="Cao H."/>
<person name="Sammak P.J."/>
<person name="Constantinescu D."/>
<person name="Schatten G.P."/>
<person name="Hegele R.A."/>
</authorList>
<dbReference type="PubMed" id="15060110"/>
<dbReference type="DOI" id="10.1136/jmg.2003.015651"/>
</citation>
<scope>VARIANT HGPS CYS-644</scope>
<scope>VARIANTS ILE-10 AND VAL-578</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2004" name="J. Med. Genet." volume="41" first="609" last="614">
<title>Homozygous missense mutation in the lamin A/C gene causes autosomal recessive Hutchinson-Gilford progeria syndrome.</title>
<authorList>
<person name="Plasilova M."/>
<person name="Chattopadhyay C."/>
<person name="Pal P."/>
<person name="Schaub N.A."/>
<person name="Buechner S.A."/>
<person name="Mueller H."/>
<person name="Miny P."/>
<person name="Ghosh A."/>
<person name="Heinimann K."/>
</authorList>
<dbReference type="PubMed" id="15286156"/>
<dbReference type="DOI" id="10.1136/jmg.2004.019661"/>
</citation>
<scope>VARIANT HGPS ASN-542</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2004" name="J. Med. Genet." volume="41" first="E29" last="E29">
<title>A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia.</title>
<authorList>
<person name="Goizet C."/>
<person name="Yaou R.B."/>
<person name="Demay L."/>
<person name="Richard P."/>
<person name="Bouillot S."/>
<person name="Rouanet M."/>
<person name="Hermosilla E."/>
<person name="Le Masson G."/>
<person name="Lagueny A."/>
<person name="Bonne G."/>
<person name="Ferrer X."/>
</authorList>
<dbReference type="PubMed" id="14985400"/>
<dbReference type="DOI" id="10.1136/jmg.2003.013383"/>
</citation>
<scope>VARIANT CMT2 ASP-33</scope>
<scope>VARIANT EDMD2 GLY-33</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2004" name="Muscle Nerve" volume="30" first="444" last="450">
<title>Nuclear envelope alterations in fibroblasts from patients with muscular dystrophy, cardiomyopathy, and partial lipodystrophy carrying lamin A/C gene mutations.</title>
<authorList>
<person name="Muchir A."/>
<person name="Medioni J."/>
<person name="Laluc M."/>
<person name="Massart C."/>
<person name="Arimura T."/>
<person name="van der Kooi A.J."/>
<person name="Desguerre I."/>
<person name="Mayer M."/>
<person name="Ferrer X."/>
<person name="Briault S."/>
<person name="Hirano M."/>
<person name="Worman H.J."/>
<person name="Mallet A."/>
<person name="Wehnert M."/>
<person name="Schwartz K."/>
<person name="Bonne G."/>
</authorList>
<dbReference type="PubMed" id="15372542"/>
<dbReference type="DOI" id="10.1002/mus.20122"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANTS EDMD2 LYS-32 DEL; SER-63; GLN-249; LYS-358; CYS-401; TRP-453 AND PRO-527</scope>
<scope>CHARACTERIZATION OF VARIANTS EDMD2 LYS-208 DEL AND HIS-377</scope>
<scope>CHARACTERIZATION OF VARIANT FPLD2 LEU-482</scope>
<scope>CHARACTERIZATION OF VARIANT CMD1A CYS-541</scope>
</reference>
<reference key="92">
<citation type="journal article" date="2005" name="Ann. Neurol." volume="57" first="148" last="151">
<title>p.S143F mutation in lamin A/C: a new phenotype combining myopathy and progeria.</title>
<authorList>
<person name="Kirschner J."/>
<person name="Brune T."/>
<person name="Wehnert M."/>
<person name="Denecke J."/>
<person name="Wasner C."/>
<person name="Feuer A."/>
<person name="Marquardt T."/>
<person name="Ketelsen U.-P."/>
<person name="Wieacker P."/>
<person name="Boennemann C.G."/>
<person name="Korinthenberg R."/>
</authorList>
<dbReference type="PubMed" id="15622532"/>
<dbReference type="DOI" id="10.1002/ana.20359"/>
</citation>
<scope>VARIANT HGPS PHE-143</scope>
</reference>
<reference key="93">
<citation type="journal article" date="2005" name="Hum. Genet." volume="117" first="298" last="298">
<title>Gene symbol: LMNA. Disease: cardiomyopathy, dilated, with conduction defect 1.</title>
<authorList>
<person name="Arbustini Eloisa A.E."/>
<person name="Pilotto A."/>
<person name="Pasotti M."/>
<person name="Grasso M."/>
<person name="Diegoli M."/>
<person name="Campana C."/>
<person name="Gavazzi A."/>
<person name="Alessandra R."/>
<person name="Tavazzi L."/>
</authorList>
<dbReference type="PubMed" id="16156025"/>
</citation>
<scope>VARIANT CMDA1 ASN-260</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2005" name="J. Clin. Endocrinol. Metab." volume="90" first="5259" last="5264">
<title>A novel homozygous Ala529Val LMNA mutation in Turkish patients with mandibuloacral dysplasia.</title>
<authorList>
<person name="Garg A."/>
<person name="Cogulu O."/>
<person name="Ozkinay F."/>
<person name="Onay H."/>
<person name="Agarwal A.K."/>
</authorList>
<dbReference type="PubMed" id="15998779"/>
<dbReference type="DOI" id="10.1210/jc.2004-2560"/>
</citation>
<scope>VARIANT MADA VAL-529</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2005" name="J. Med. Genet." volume="42" first="214" last="220">
<title>Lamin A N-terminal phosphorylation is associated with myoblast activation: impairment in Emery-Dreifuss muscular dystrophy.</title>
<authorList>
<person name="Cenni V."/>
<person name="Sabatelli P."/>
<person name="Mattioli E."/>
<person name="Marmiroli S."/>
<person name="Capanni C."/>
<person name="Ognibene A."/>
<person name="Squarzoni S."/>
<person name="Maraldi N.M."/>
<person name="Bonne G."/>
<person name="Columbaro M."/>
<person name="Merlini L."/>
<person name="Lattanzi G."/>
</authorList>
<dbReference type="PubMed" id="15744034"/>
<dbReference type="DOI" id="10.1136/jmg.2004.026112"/>
</citation>
<scope>VARIANT EDMD2 HIS-377</scope>
<scope>VARIANTS EDMD2 ASN-63; PRO-140; GLN-190; GLN-249 AND PRO-527</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2006" name="J. Clin. Endocrinol. Metab." volume="91" first="517" last="521">
<title>A homozygous mutation in the lamin A/C gene associated with a novel syndrome of arthropathy, tendinous calcinosis, and progeroid features.</title>
<authorList>
<person name="Van Esch H."/>
<person name="Agarwal A.K."/>
<person name="Debeer P."/>
<person name="Fryns J.-P."/>
<person name="Garg A."/>
</authorList>
<dbReference type="PubMed" id="16278265"/>
<dbReference type="DOI" id="10.1210/jc.2005-1297"/>
</citation>
<scope>VARIANT MADA LEU-573</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2007" name="Biochem. Biophys. Res. Commun." volume="352" first="603" last="608">
<title>Collagen expression in fibroblasts with a novel LMNA mutation.</title>
<authorList>
<person name="Nguyen D."/>
<person name="Leistritz D.F."/>
<person name="Turner L."/>
<person name="MacGregor D."/>
<person name="Ohson K."/>
<person name="Dancey P."/>
<person name="Martin G.M."/>
<person name="Oshima J."/>
</authorList>
<dbReference type="PubMed" id="17150192"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.11.070"/>
</citation>
<scope>VARIANT CMDHH ARG-59</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2007" name="Clin. Genet." volume="71" first="183" last="186">
<title>Novel LMNA mutations seen in patients with familial partial lipodystrophy subtype 2 (FPLD2; MIM 151660).</title>
<authorList>
<person name="Lanktree M."/>
<person name="Cao H."/>
<person name="Rabkin S.W."/>
<person name="Hanna A."/>
<person name="Hegele R.A."/>
</authorList>
<dbReference type="PubMed" id="17250669"/>
<dbReference type="DOI" id="10.1111/j.1399-0004.2007.00740.x"/>
</citation>
<scope>VARIANTS FPLD2 ASN-230; CYS-399 AND LEU-573</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2007" name="Neurogenetics" volume="8" first="137" last="142">
<title>Mutations of the LMNA gene can mimic autosomal dominant proximal spinal muscular atrophy.</title>
<authorList>
<person name="Rudnik-Schoeneborn S."/>
<person name="Botzenhart E."/>
<person name="Eggermann T."/>
<person name="Senderek J."/>
<person name="Schoser B.G.H."/>
<person name="Schroeder R."/>
<person name="Wehnert M."/>
<person name="Wirth B."/>
<person name="Zerres K."/>
</authorList>
<dbReference type="PubMed" id="17136397"/>
<dbReference type="DOI" id="10.1007/s10048-006-0070-0"/>
</citation>
<scope>VARIANT EDMD2 HIS-377</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2007" name="J. Clin. Endocrinol. Metab." volume="92" first="4835" last="4844">
<title>New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome.</title>
<authorList>
<person name="Decaudain A."/>
<person name="Vantyghem M.C."/>
<person name="Guerci B."/>
<person name="Hecart A.C."/>
<person name="Auclair M."/>
<person name="Reznik Y."/>
<person name="Narbonne H."/>
<person name="Ducluzeau P.H."/>
<person name="Donadille B."/>
<person name="Lebbe C."/>
<person name="Bereziat V."/>
<person name="Capeau J."/>
<person name="Lascols O."/>
<person name="Vigouroux C."/>
</authorList>
<dbReference type="PubMed" id="17711925"/>
<dbReference type="DOI" id="10.1210/jc.2007-0654"/>
</citation>
<scope>VARIANT PRO-421</scope>
</reference>
<reference key="101">
<citation type="journal article" date="2008" name="Ann. Neurol." volume="64" first="177" last="186">
<title>De novo LMNA mutations cause a new form of congenital muscular dystrophy.</title>
<authorList>
<person name="Quijano-Roy S."/>
<person name="Mbieleu B."/>
<person name="Bonnemann C.G."/>
<person name="Jeannet P.Y."/>
<person name="Colomer J."/>
<person name="Clarke N.F."/>
<person name="Cuisset J.M."/>
<person name="Roper H."/>
<person name="De Meirleir L."/>
<person name="D'Amico A."/>
<person name="Ben Yaou R."/>
<person name="Nascimento A."/>
<person name="Barois A."/>
<person name="Demay L."/>
<person name="Bertini E."/>
<person name="Ferreiro A."/>
<person name="Sewry C.A."/>
<person name="Romero N.B."/>
<person name="Ryan M."/>
<person name="Muntoni F."/>
<person name="Guicheney P."/>
<person name="Richard P."/>
<person name="Bonne G."/>
<person name="Estournet B."/>
</authorList>
<dbReference type="PubMed" id="18551513"/>
<dbReference type="DOI" id="10.1002/ana.21417"/>
</citation>
<scope>VARIANTS MDCL SER-39; PRO-50; TRP-249; PRO-302; LYS-358; SER-380; PRO-453; PRO-455 AND ASP-456</scope>
</reference>
<reference key="102">
<citation type="journal article" date="2008" name="J. Med. Genet." volume="45" first="666" last="671">
<title>Heart-hand syndrome of Slovenian type: a new kind of laminopathy.</title>
<authorList>
<person name="Renou L."/>
<person name="Stora S."/>
<person name="Yaou R.B."/>
<person name="Volk M."/>
<person name="Sinkovec M."/>
<person name="Demay L."/>
<person name="Richard P."/>
<person name="Peterlin B."/>
<person name="Bonne G."/>
</authorList>
<dbReference type="PubMed" id="18611980"/>
<dbReference type="DOI" id="10.1136/jmg.2008.060020"/>
</citation>
<scope>INVOLVEMENT IN HHS-SLOVENIAN</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="103">
<citation type="journal article" date="2009" name="Am. J. Med. Genet. A" volume="149" first="567" last="572">
<title>Ovarian failure and dilated cardiomyopathy due to a novel lamin mutation.</title>
<authorList>
<person name="McPherson E."/>
<person name="Turner L."/>
<person name="Zador I."/>
<person name="Reynolds K."/>
<person name="Macgregor D."/>
<person name="Giampietro P.F."/>
</authorList>
<dbReference type="PubMed" id="19283854"/>
<dbReference type="DOI" id="10.1002/ajmg.a.32627"/>
</citation>
<scope>VARIANT CMDHH ARG-59</scope>
</reference>
<reference key="104">
<citation type="journal article" date="2009" name="Am. J. Cardiol." volume="103" first="1426" last="1428">
<title>Comprehensive mutation scanning of LMNA in 268 patients with lone atrial fibrillation.</title>
<authorList>
<person name="Brauch K.M."/>
<person name="Chen L.Y."/>
<person name="Olson T.M."/>
</authorList>
<dbReference type="PubMed" id="19427440"/>
<dbReference type="DOI" id="10.1016/j.amjcard.2009.01.354"/>
</citation>
<scope>VARIANTS SER-125; ILE-415 AND PRO-488</scope>
</reference>
<reference key="105">
<citation type="journal article" date="2010" name="Int. J. Cardiol." volume="144" first="E51" last="E53">
<title>Dilated cardiomyopathy with profound segmental wall motion abnormalities and ventricular arrhythmia caused by the R541C mutation in the LMNA gene.</title>
<authorList>
<person name="Saj M."/>
<person name="Jankowska A."/>
<person name="Lewandowski M."/>
<person name="Szwed H."/>
<person name="Szperl M."/>
<person name="Ploski R."/>
<person name="Bilinska Z.T."/>
</authorList>
<dbReference type="PubMed" id="19167105"/>
<dbReference type="DOI" id="10.1016/j.ijcard.2008.12.083"/>
</citation>
<scope>VARIANT CMD1A CYS-541</scope>
</reference>
<reference key="106">
<citation type="journal article" date="2011" name="Eur. J. Med. Genet." volume="54" first="E570" last="E575">
<title>Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.</title>
<authorList>
<person name="Millat G."/>
<person name="Bouvagnet P."/>
<person name="Chevalier P."/>
<person name="Sebbag L."/>
<person name="Dulac A."/>
<person name="Dauphin C."/>
<person name="Jouk P.S."/>
<person name="Delrue M.A."/>
<person name="Thambo J.B."/>
<person name="Le Metayer P."/>
<person name="Seronde M.F."/>
<person name="Faivre L."/>
<person name="Eicher J.C."/>
<person name="Rousson R."/>
</authorList>
<dbReference type="PubMed" id="21846512"/>
<dbReference type="DOI" id="10.1016/j.ejmg.2011.07.005"/>
</citation>
<scope>VARIANTS CMD1A PHE-92; LYS-161; LYS-317 AND ARG-523</scope>
</reference>
<reference key="107">
<citation type="journal article" date="2011" name="Eur. J. Med. Genet." volume="54" first="E576" last="E579">
<title>LMNA mutation in progeroid syndrome in association with strokes.</title>
<authorList>
<person name="Gonzalez-Quereda L."/>
<person name="Delgadillo V."/>
<person name="Juan-Mateu J."/>
<person name="Verdura E."/>
<person name="Rodriguez M.J."/>
<person name="Baiget M."/>
<person name="Pineda M."/>
<person name="Gallano P."/>
</authorList>
<dbReference type="PubMed" id="21791255"/>
<dbReference type="DOI" id="10.1016/j.ejmg.2011.06.012"/>
</citation>
<scope>VARIANT HGPS LYS-138</scope>
</reference>
<reference key="108">
<citation type="journal article" date="2011" name="Hum. Mutat." volume="32" first="152" last="167">
<title>Novel LMNA mutations in patients with Emery-Dreifuss muscular dystrophy and functional characterization of four LMNA mutations.</title>
<authorList>
<person name="Scharner J."/>
<person name="Brown C.A."/>
<person name="Bower M."/>
<person name="Iannaccone S.T."/>
<person name="Khatri I.A."/>
<person name="Escolar D."/>
<person name="Gordon E."/>
<person name="Felice K."/>
<person name="Crowe C.A."/>
<person name="Grosmann C."/>
<person name="Meriggioli M.N."/>
<person name="Asamoah A."/>
<person name="Gordon O."/>
<person name="Gnocchi V.F."/>
<person name="Ellis J.A."/>
<person name="Mendell J.R."/>
<person name="Zammit P.S."/>
</authorList>
<dbReference type="PubMed" id="20848652"/>
<dbReference type="DOI" id="10.1002/humu.21361"/>
</citation>
<scope>VARIANTS EDMD2 SER-39; CYS-45; PRO-150; PRO-189; ARG-190 INS; LEU-206; TRP-249; GLN-249; PRO-268; PRO-271; PRO-294; PRO-295; PRO-303; GLN-355 DEL; LYS-358; LYS-361; LYS-386; ASP-449; TRP-453; PRO-454; TYR-461; ARG-467; PRO-527; LYS-528; ARG-528; SER-541; PRO-541; SER-602 AND CYS-644</scope>
<scope>CHARACTERIZATION OF VARIANTS EDMD2 PRO-25; TRP-249; ILE-456 AND PRO-541</scope>
</reference>
<reference key="109">
<citation type="journal article" date="2011" name="Hum. Mol. Genet." volume="20" first="3779" last="3786">
<title>High prevalence of laminopathies among patients with metabolic syndrome.</title>
<authorList>
<person name="Dutour A."/>
<person name="Roll P."/>
<person name="Gaborit B."/>
<person name="Courrier S."/>
<person name="Alessi M.C."/>
<person name="Tregouet D.A."/>
<person name="Angelis F."/>
<person name="Robaglia-Schlupp A."/>
<person name="Lesavre N."/>
<person name="Cau P."/>
<person name="Levy N."/>
<person name="Badens C."/>
<person name="Morange P.E."/>
</authorList>
<dbReference type="PubMed" id="21724554"/>
<dbReference type="DOI" id="10.1093/hmg/ddr294"/>
</citation>
<scope>VARIANTS ASP-411 AND ASP-631</scope>
</reference>
<reference key="110">
<citation type="journal article" date="2012" name="Muscle Nerve" volume="45" first="605" last="610">
<title>Autosomal recessive Emery-Dreifuss muscular dystrophy caused by a novel mutation (R225Q) in the lamin A/C gene identified by exome sequencing.</title>
<authorList>
<person name="Jimenez-Escrig A."/>
<person name="Gobernado I."/>
<person name="Garcia-Villanueva M."/>
<person name="Sanchez-Herranz A."/>
</authorList>
<dbReference type="PubMed" id="22431096"/>
<dbReference type="DOI" id="10.1002/mus.22324"/>
</citation>
<scope>VARIANT EDMD3 GLN-225</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="111">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E71850" last="E71850">
<title>Mutations in LMNA modulate the lamin A--Nesprin-2 interaction and cause LINC complex alterations.</title>
<authorList>
<person name="Yang L."/>
<person name="Munck M."/>
<person name="Swamvdinathan K."/>
<person name="Kapinos L.E."/>
<person name="Noegel A.A."/>
<person name="Neumann S."/>
</authorList>
<dbReference type="PubMed" id="23977161"/>
<dbReference type="DOI" id="10.1371/journal.pone.0071850"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS CYS-401; ASP-411; CYS-413; ILE-415; CYS-419; PRO-421 AND GLY-427</scope>
<scope>INTERACTION WITH SYNE2</scope>
</reference>
<reference key="112">
<citation type="journal article" date="2014" name="Diabetes Metab." volume="40" first="224" last="228">
<title>LMNA gene mutation as a model of cardiometabolic dysfunction: from genetic analysis to treatment response.</title>
<authorList>
<person name="Chirico V."/>
<person name="Ferrau V."/>
<person name="Loddo I."/>
<person name="Briuglia S."/>
<person name="Amorini M."/>
<person name="Salpietro V."/>
<person name="Lacquaniti A."/>
<person name="Salpietro C."/>
<person name="Arrigo T."/>
</authorList>
<dbReference type="PubMed" id="24485160"/>
<dbReference type="DOI" id="10.1016/j.diabet.2013.12.008"/>
</citation>
<scope>VARIANT FPLD2 GLU-515</scope>
</reference>
<reference key="113">
<citation type="journal article" date="2017" name="Clin. Genet." volume="91" first="386" last="402">
<title>Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population.</title>
<authorList>
<person name="Fattahi Z."/>
<person name="Kalhor Z."/>
<person name="Fadaee M."/>
<person name="Vazehan R."/>
<person name="Parsimehr E."/>
<person name="Abolhassani A."/>
<person name="Beheshtian M."/>
<person name="Zamani G."/>
<person name="Nafissi S."/>
<person name="Nilipour Y."/>
<person name="Akbari M.R."/>
<person name="Kahrizi K."/>
<person name="Kariminejad A."/>
<person name="Najmabadi H."/>
</authorList>
<dbReference type="PubMed" id="27234031"/>
<dbReference type="DOI" id="10.1111/cge.12810"/>
</citation>
<scope>VARIANT EDMD3 SER-24</scope>
<scope>VARIANT EDMD2 CYS-259</scope>
</reference>
<comment type="function">
<text evidence="30 32 33 37 44 48 60 68 80 82 98 99">Lamins are components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane, which is thought to provide a framework for the nuclear envelope and may also interact with chromatin. Lamin A and C are present in equal amounts in the lamina of mammals. Plays an important role in nuclear assembly, chromatin organization, nuclear membrane and telomere dynamics. Required for normal development of peripheral nervous system and skeletal muscle and for muscle satellite cell proliferation (PubMed:10080180, PubMed:22431096, PubMed:10814726, PubMed:11799477, PubMed:18551513). Required for osteoblastogenesis and bone formation (PubMed:12075506, PubMed:15317753, PubMed:18611980). Also prevents fat infiltration of muscle and bone marrow, helping to maintain the volume and strength of skeletal muscle and bone (PubMed:10587585). Required for cardiac homeostasis (PubMed:10580070, PubMed:12927431, PubMed:18611980, PubMed:23666920).</text>
</comment>
<comment type="function">
<text>Prelamin-A/C can accelerate smooth muscle cell senescence. It acts to disrupt mitosis and induce DNA damage in vascular smooth muscle cells (VSMCs), leading to mitotic failure, genomic instability, and premature senescence.</text>
</comment>
<comment type="subunit">
<text evidence="24 31 51 86 88 92 96 100 101 104">Homodimer of lamin A and lamin C. Interacts with lamin-associated polypeptides IA, IB and TMPO-alpha, RB1 and with emerin. Interacts with SREBF1, SREBF2, SUN2 and TMEM43. Interacts with TMEM201 (By similarity). Proteolytically processed isoform A interacts with NARF. Interacts with SUN1. Prelamin-A/C interacts with EMD. Interacts with MLIP. Interacts with DMPK; may regulate nuclear envelope stability. Interacts with SUV39H1; the interaction increases stability of SUV39H1. Interacts with SYNE2. Interacts with ITSN1 isoform 2 (PubMed:29599122).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-1633210">
<id>P18054</id>
<label>ALOX12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-749800">
<id>Q9UII6</id>
<label>DUSP13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-489887">
<id>P50402</id>
<label>EMD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-494830">
<id>P16104</id>
<label>H2AX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-750650">
<id>Q71DI3</id>
<label>H3C15</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-10172290">
<id>P60409</id>
<label>KRTAP10-7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-968218">
<id>P20700</id>
<label>LMNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-2830427">
<id>Q03252</id>
<label>LMNB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-1042651">
<id>Q96RG2</id>
<label>PASK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-448369">
<id>Q96FA3</id>
<label>PELI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-1044964">
<id>Q9UH99</id>
<label>SUN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-6170976">
<id>Q8WXH0-1</id>
<label>SYNE2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-395393">
<id>P42166</id>
<label>TMPO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-10273713">
<id>Q8TBZ8</id>
<label>ZNF564</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-7183650">
<id>P10215</id>
<label>NEC1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351935">
<id>P02545</id>
</interactant>
<interactant intactId="EBI-7183680">
<id>P10218</id>
<label>NEC2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351949">
<id>P02545-1</id>
</interactant>
<interactant intactId="EBI-489887">
<id>P50402</id>
<label>EMD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351949">
<id>P02545-1</id>
</interactant>
<interactant intactId="EBI-968218">
<id>P20700</id>
<label>LMNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351949">
<id>P02545-1</id>
</interactant>
<interactant intactId="EBI-22057616">
<id>PRO_0000314029</id>
<label>SREBF1</label>
<dbReference type="UniProtKB" id="P36956"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351949">
<id>P02545-1</id>
</interactant>
<interactant intactId="EBI-1056377">
<id>O75844</id>
<label>ZMPSTE24</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351953">
<id>P02545-2</id>
</interactant>
<interactant intactId="EBI-351953">
<id>P02545-2</id>
<label>LMNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351953">
<id>P02545-2</id>
</interactant>
<interactant intactId="EBI-968218">
<id>P20700</id>
<label>LMNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>19</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-351953">
<id>P02545-2</id>
</interactant>
<interactant intactId="EBI-6872807">
<id>Q8N0S2</id>
<label>SYCE1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-9034379">
<id>P02545-6</id>
</interactant>
<interactant intactId="EBI-750650">
<id>Q71DI3</id>
<label>H3C15</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="69">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="104">Nucleus envelope</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus lamina</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleoplasm</location>
</subcellularLocation>
<text>Farnesylation of prelamin-A/C facilitates nuclear envelope targeting and subsequent cleavage by ZMPSTE24/FACE1 to remove the farnesyl group produces mature lamin-A/C, which can then be inserted into the nuclear lamina. EMD is required for proper localization of non-farnesylated prelamin-A/C.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform C</molecule>
<subcellularLocation>
<location evidence="73">Nucleus speckle</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P02545-1</id>
<name>A</name>
<name>Lamin A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P02545-2</id>
<name>C</name>
<name>Lamin C</name>
<sequence type="described" ref="VSP_002469 VSP_002470"/>
</isoform>
<isoform>
<id>P02545-3</id>
<name>ADelta10</name>
<name>Lamin ADelta10</name>
<sequence type="described" ref="VSP_002468"/>
</isoform>
<isoform>
<id>P02545-4</id>
<name>4</name>
<sequence type="described" ref="VSP_045977 VSP_045978 VSP_045979"/>
</isoform>
<isoform>
<id>P02545-5</id>
<name>5</name>
<sequence type="described" ref="VSP_053503 VSP_053504"/>
</isoform>
<isoform>
<id>P02545-6</id>
<name>6</name>
<name>Progerin</name>
<sequence type="described" ref="VSP_053505"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="90">In the arteries, prelamin-A/C accumulation is not observed in young healthy vessels but is prevalent in medial vascular smooth muscle cells (VSMCs) from aged individuals and in atherosclerotic lesions, where it often colocalizes with senescent and degenerate VSMCs. Prelamin-A/C expression increases with age and disease. In normal aging, the accumulation of prelamin-A/C is caused in part by the down-regulation of ZMPSTE24/FACE1 in response to oxidative stress.</text>
</comment>
<comment type="PTM">
<text evidence="107">Increased phosphorylation of the lamins occurs before envelope disintegration and probably plays a role in regulating lamin associations.</text>
</comment>
<comment type="PTM">
<text evidence="90 105 106">Proteolytic cleavage of the C-terminal of 18 residues of prelamin-A/C results in the production of lamin-A/C. The prelamin-A/C maturation pathway includes farnesylation of CAAX motif, ZMPSTE24/FACE1 mediated cleavage of the last three amino acids, methylation of the C-terminal cysteine and endoproteolytic removal of the last 15 C-terminal amino acids. Proteolytic cleavage requires prior farnesylation and methylation, and absence of these blocks cleavage.</text>
</comment>
<comment type="PTM">
<text evidence="81">Sumoylation is necessary for the localization to the nuclear envelope.</text>
</comment>
<comment type="PTM">
<text>Farnesylation of prelamin-A/C facilitates nuclear envelope targeting.</text>
</comment>
<comment type="disease" evidence="30 36 37 38 39 40 41 43 47 50 55 56 62 63 69 71 76 88 91 103">
<disease id="DI-01520">
<name>Emery-Dreifuss muscular dystrophy 2, autosomal dominant</name>
<acronym>EDMD2</acronym>
<description>A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.</description>
<dbReference type="MIM" id="181350"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="98 103">
<disease id="DI-03418">
<name>Emery-Dreifuss muscular dystrophy 3, autosomal recessive</name>
<acronym>EDMD3</acronym>
<description>A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.</description>
<dbReference type="MIM" id="616516"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="32 42 43 45 52 53 59 61 62 65 66 69 73 81 83 89 95">
<disease id="DI-00210">
<name>Cardiomyopathy, dilated 1A</name>
<acronym>CMD1A</acronym>
<description>A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.</description>
<dbReference type="MIM" id="115200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="33 34 35 43 46 49 54 69 78 84 102">
<disease id="DI-01595">
<name>Lipodystrophy, familial partial, 2</name>
<acronym>FPLD2</acronym>
<description>A disorder characterized by the loss of subcutaneous adipose tissue in the lower parts of the body (limbs, buttocks, trunk). It is accompanied by an accumulation of adipose tissue in the face and neck causing a double chin, fat neck, or cushingoid appearance. Adipose tissue may also accumulate in the axillae, back, labia majora, and intraabdominal region. Affected patients are insulin-resistant and may develop glucose intolerance and diabetes mellitus after age 20 years, hypertriglyceridemia, and low levels of high density lipoprotein cholesterol.</description>
<dbReference type="MIM" id="151660"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="44">
<disease id="DI-00277">
<name>Charcot-Marie-Tooth disease 2B1</name>
<acronym>CMT2B1</acronym>
<description>A recessive axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.</description>
<dbReference type="MIM" id="605588"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="57 58 60 64 67 70 88 94 97 99">
<disease id="DI-01757">
<name>Hutchinson-Gilford progeria syndrome</name>
<acronym>HGPS</acronym>
<description>Rare genetic disorder characterized by features reminiscent of marked premature aging.</description>
<dbReference type="MIM" id="176670"/>
</disease>
<text evidence="57">The disease is caused by mutations affecting the gene represented in this entry. HGPS is caused by the toxic accumulation of a truncated form of lamin-A/C. This mutant protein, called progerin (isoform 6), acts to deregulate mitosis and DNA damage signaling, leading to premature cell death and senescence. The mutant form is mainly generated by a silent or missense mutation at codon 608 of prelamin A that causes activation of a cryptic splice donor site, resulting in production of isoform 6 with a deletion of 50 amino acids near the C terminus. Progerin lacks the conserved ZMPSTE24/FACE1 cleavage site and therefore remains permanently farnesylated. Thus, although it can enter the nucleus and associate with the nuclear envelope, it cannot incorporate normally into the nuclear lamina (PubMed:12714972).</text>
</comment>
<comment type="disease" evidence="60 77 85">
<disease id="DI-02906">
<name>Cardiomyopathy, dilated, with hypergonadotropic hypogonadism</name>
<acronym>CMDHH</acronym>
<description>A disorder characterized by the association of genital anomalies, hypergonadotropic hypogonadism and dilated cardiomyopathy. Patients can present other variable clinical manifestations including mental retardation, skeletal anomalies, scleroderma-like skin, graying and thinning of hair, osteoporosis. Dilated cardiomyopathy is characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia.</description>
<dbReference type="MIM" id="212112"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="48 72 75">
<disease id="DI-01932">
<name>Mandibuloacral dysplasia with type A lipodystrophy</name>
<acronym>MADA</acronym>
<description>A disorder characterized by mandibular and clavicular hypoplasia, acroosteolysis, delayed closure of the cranial suture, progeroid appearance, partial alopecia, soft tissue calcinosis, joint contractures, and partial lipodystrophy with loss of subcutaneous fat from the extremities. Adipose tissue in the face, neck and trunk is normal or increased.</description>
<dbReference type="MIM" id="248370"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="68">
<disease id="DI-01894">
<name>Lethal tight skin contracture syndrome</name>
<acronym>LTSCS</acronym>
<description>Rare disorder mainly characterized by intrauterine growth retardation, tight and rigid skin with erosions, prominent superficial vasculature and epidermal hyperkeratosis, facial features (small mouth, small pinched nose and micrognathia), sparse/absent eyelashes and eyebrows, mineralization defects of the skull, thin dysplastic clavicles, pulmonary hypoplasia, multiple joint contractures and an early neonatal lethal course. Liveborn children usually die within the first week of life. The overall prevalence of consanguineous cases suggested an autosomal recessive inheritance.</description>
<dbReference type="MIM" id="275210"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="82">
<disease id="DI-01697">
<name>Heart-hand syndrome Slovenian type</name>
<acronym>HHS-Slovenian</acronym>
<description>Heart-hand syndrome (HHS) is a clinically and genetically heterogeneous disorder characterized by the co-occurrence of a congenital cardiac disease and limb malformations.</description>
<dbReference type="MIM" id="610140"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="80">
<disease id="DI-02702">
<name>Muscular dystrophy congenital LMNA-related</name>
<acronym>MDCL</acronym>
<description>A form of congenital muscular dystrophy. Patients present at birth, or within the first few months of life, with hypotonia, muscle weakness and often with joint contractures.</description>
<dbReference type="MIM" id="613205"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="99">Defects in LMNA may cause a late-onset cardiocutaneous progeria syndrome characterized by cutaneous manifestations of aging appearing in the third decade of life, cardiac valve calcification and dysfunction, prominent atherosclerosis, and cardiomyopathy, leading to death on average in the fourth decade.</text>
</comment>
<comment type="miscellaneous">
<text>There are three types of lamins in human cells: A, B, and C.</text>
</comment>
<comment type="miscellaneous">
<text>The structural integrity of the lamina is strictly controlled by the cell cycle, as seen by the disintegration and formation of the nuclear envelope in prophase and telophase, respectively.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 6</molecule>
<text evidence="114">Disease-associated isoform. Polymorphism at codon 608 results in activation of a cryptic splice donor site within exon 11, resulting in a truncated protein product that lacks the site for endoproteolytic cleavage.</text>
</comment>
<comment type="similarity">
<text evidence="29">Belongs to the intermediate filament family.</text>
</comment>
<comment type="sequence caution" evidence="114">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="CAA27173" version="1"/>
</conflict>
</comment>
<comment type="online information" name="Human Intermediate Filament Mutation Database">
<link uri="http://www.interfil.org"/>
</comment>
<dbReference type="EMBL" id="X03444">
<property type="protein sequence ID" value="CAA27173.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X03445">
<property type="protein sequence ID" value="CAA27174.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M13451">
<property type="protein sequence ID" value="AAA36164.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M13452">
<property type="protein sequence ID" value="AAA36160.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY847597">
<property type="protein sequence ID" value="AAW32540.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY847595">
<property type="protein sequence ID" value="AAW32538.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY357727">
<property type="protein sequence ID" value="AAR29466.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295390">
<property type="protein sequence ID" value="BAG58344.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL135927">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL355388">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356734">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW52997.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW52999.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000511">
<property type="protein sequence ID" value="AAH00511.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003162">
<property type="protein sequence ID" value="AAH03162.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC014507">
<property type="protein sequence ID" value="AAH14507.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF381029">
<property type="protein sequence ID" value="AAK59326.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1129.1">
<molecule id="P02545-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1131.1">
<molecule id="P02545-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58038.1">
<molecule id="P02545-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS72941.1">
<molecule id="P02545-6"/>
</dbReference>
<dbReference type="PIR" id="A02961">
<property type="entry name" value="VEHULA"/>
</dbReference>
<dbReference type="PIR" id="A02962">
<property type="entry name" value="VEHULC"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001244303.1">
<molecule id="P02545-4"/>
<property type="nucleotide sequence ID" value="NM_001257374.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001269553.1">
<property type="nucleotide sequence ID" value="NM_001282624.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001269554.1">
<molecule id="P02545-2"/>
<property type="nucleotide sequence ID" value="NM_001282625.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001269555.1">
<molecule id="P02545-6"/>
<property type="nucleotide sequence ID" value="NM_001282626.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005563.1">
<molecule id="P02545-2"/>
<property type="nucleotide sequence ID" value="NM_005572.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_733821.1">
<molecule id="P02545-1"/>
<property type="nucleotide sequence ID" value="NM_170707.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_733822.1">
<molecule id="P02545-3"/>
<property type="nucleotide sequence ID" value="NM_170708.3"/>
</dbReference>
<dbReference type="PDB" id="1IFR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=436-552"/>
</dbReference>
<dbReference type="PDB" id="1IVT">
<property type="method" value="NMR"/>
<property type="chains" value="A=428-549"/>
</dbReference>
<dbReference type="PDB" id="1X8Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=305-387"/>
</dbReference>
<dbReference type="PDB" id="2XV5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=328-398"/>
</dbReference>
<dbReference type="PDB" id="2YPT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="F/G/H/I=661-664"/>
</dbReference>
<dbReference type="PDB" id="3GEF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A/B/C/D=436-552"/>
</dbReference>
<dbReference type="PDB" id="3V4Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.06"/>
<property type="chains" value="A=313-386"/>
</dbReference>
<dbReference type="PDB" id="3V4W">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A=313-386"/>
</dbReference>
<dbReference type="PDB" id="3V5B">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=313-386"/>
</dbReference>
<dbReference type="PDB" id="6GHD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="B/F=428-546"/>
</dbReference>
<dbReference type="PDB" id="6JLB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A/B/C/D=1-300"/>
</dbReference>
<dbReference type="PDB" id="6RPR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.26"/>
<property type="chains" value="B=430-545"/>
</dbReference>
<dbReference type="PDB" id="6SNZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B/C/D=65-222"/>
</dbReference>
<dbReference type="PDBsum" id="1IFR"/>
<dbReference type="PDBsum" id="1IVT"/>
<dbReference type="PDBsum" id="1X8Y"/>
<dbReference type="PDBsum" id="2XV5"/>
<dbReference type="PDBsum" id="2YPT"/>
<dbReference type="PDBsum" id="3GEF"/>
<dbReference type="PDBsum" id="3V4Q"/>
<dbReference type="PDBsum" id="3V4W"/>
<dbReference type="PDBsum" id="3V5B"/>
<dbReference type="PDBsum" id="6GHD"/>
<dbReference type="PDBsum" id="6JLB"/>
<dbReference type="PDBsum" id="6RPR"/>
<dbReference type="PDBsum" id="6SNZ"/>
<dbReference type="BMRB" id="P02545"/>
<dbReference type="SMR" id="P02545"/>
<dbReference type="BioGRID" id="110186">
<property type="interactions" value="819"/>
</dbReference>
<dbReference type="CORUM" id="P02545"/>
<dbReference type="DIP" id="DIP-32948N"/>
<dbReference type="DIP" id="DIP-58162N"/>
<dbReference type="IntAct" id="P02545">
<property type="interactions" value="280"/>
</dbReference>
<dbReference type="MINT" id="P02545"/>
<dbReference type="STRING" id="9606.ENSP00000357283"/>
<dbReference type="ChEMBL" id="CHEMBL1293235"/>
<dbReference type="GlyConnect" id="2876">
<molecule id="P02545-3"/>
<property type="glycosylation" value="1 O-Linked glycan (2 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="P02545">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="P02545"/>
<dbReference type="MetOSite" id="P02545"/>
<dbReference type="PhosphoSitePlus" id="P02545"/>
<dbReference type="SwissPalm" id="P02545"/>
<dbReference type="BioMuta" id="LMNA"/>
<dbReference type="DMDM" id="125962"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00021405"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00216952"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P02545"/>
<dbReference type="SWISS-2DPAGE" id="P02545"/>
<dbReference type="CPTAC" id="CPTAC-399"/>
<dbReference type="CPTAC" id="CPTAC-400"/>
<dbReference type="CPTAC" id="CPTAC-973"/>
<dbReference type="CPTAC" id="CPTAC-974"/>
<dbReference type="EPD" id="P02545"/>
<dbReference type="jPOST" id="P02545"/>
<dbReference type="MassIVE" id="P02545"/>
<dbReference type="MaxQB" id="P02545"/>
<dbReference type="PaxDb" id="P02545"/>
<dbReference type="PeptideAtlas" id="P02545"/>
<dbReference type="PRIDE" id="P02545"/>
<dbReference type="ProteomicsDB" id="13394"/>
<dbReference type="ProteomicsDB" id="18441"/>
<dbReference type="ProteomicsDB" id="51530">
<molecule id="P02545-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51531">
<molecule id="P02545-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51532">
<molecule id="P02545-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="67698"/>
<dbReference type="TopDownProteomics" id="P02545-1">
<molecule id="P02545-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P02545-2">
<molecule id="P02545-2"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P02545-4">
<molecule id="P02545-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="1676">
<property type="antibodies" value="1574 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4000"/>
<dbReference type="Ensembl" id="ENST00000347559">
<molecule id="P02545-3"/>
<property type="protein sequence ID" value="ENSP00000292304"/>
<property type="gene ID" value="ENSG00000160789"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368299">
<molecule id="P02545-6"/>
<property type="protein sequence ID" value="ENSP00000357282"/>
<property type="gene ID" value="ENSG00000160789"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368300">
<molecule id="P02545-1"/>
<property type="protein sequence ID" value="ENSP00000357283"/>
<property type="gene ID" value="ENSG00000160789"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368301">
<molecule id="P02545-2"/>
<property type="protein sequence ID" value="ENSP00000357284"/>
<property type="gene ID" value="ENSG00000160789"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000448611">
<molecule id="P02545-4"/>
<property type="protein sequence ID" value="ENSP00000395597"/>
<property type="gene ID" value="ENSG00000160789"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000473598">
<molecule id="P02545-5"/>
<property type="protein sequence ID" value="ENSP00000421821"/>
<property type="gene ID" value="ENSG00000160789"/>
</dbReference>
<dbReference type="GeneID" id="4000"/>
<dbReference type="KEGG" id="hsa:4000"/>
<dbReference type="UCSC" id="uc001fnf.3">
<molecule id="P02545-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4000"/>
<dbReference type="DisGeNET" id="4000"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160789.19"/>
<dbReference type="GeneCards" id="LMNA"/>
<dbReference type="GeneReviews" id="LMNA"/>
<dbReference type="HGNC" id="HGNC:6636">
<property type="gene designation" value="LMNA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000160789">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="LMNA"/>
<dbReference type="MIM" id="115200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="150330">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="151660">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="176670">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="181350">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="212112">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="248370">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="275210">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="605588">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="610140">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613205">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616516">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P02545"/>
<dbReference type="OpenTargets" id="ENSG00000160789"/>
<dbReference type="Orphanet" id="79474">
<property type="disease" value="Atypical Werner syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="98853">
<property type="disease" value="Autosomal dominant Emery-Dreifuss muscular dystrophy"/>
</dbReference>
<dbReference type="Orphanet" id="98855">
<property type="disease" value="Autosomal recessive Emery-Dreifuss muscular dystrophy"/>
</dbReference>
<dbReference type="Orphanet" id="280365">
<property type="disease" value="Autosomal semi-dominant severe lipodystrophic laminopathy"/>
</dbReference>
<dbReference type="Orphanet" id="98856">
<property type="disease" value="Charcot-Marie-Tooth disease type 2B1"/>
</dbReference>
<dbReference type="Orphanet" id="157973">
<property type="disease" value="Congenital muscular dystrophy due to LMNA mutation"/>
</dbReference>
<dbReference type="Orphanet" id="2229">
<property type="disease" value="Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="300751">
<property type="disease" value="Familial dilated cardiomyopathy with conduction defect due to LMNA mutation"/>
</dbReference>
<dbReference type="Orphanet" id="293899">
<property type="disease" value="Familial isolated arrhythmogenic ventricular dysplasia, biventricular form"/>
</dbReference>
<dbReference type="Orphanet" id="293888">
<property type="disease" value="Familial isolated arrhythmogenic ventricular dysplasia, left dominant form"/>
</dbReference>
<dbReference type="Orphanet" id="293910">
<property type="disease" value="Familial isolated arrhythmogenic ventricular dysplasia, right dominant form"/>
</dbReference>
<dbReference type="Orphanet" id="2348">
<property type="disease" value="Familial partial lipodystrophy, Dunnigan type"/>
</dbReference>
<dbReference type="Orphanet" id="79084">
<property type="disease" value="Familial partial lipodystrophy, Koebberling type"/>
</dbReference>
<dbReference type="Orphanet" id="168796">
<property type="disease" value="Heart-hand syndrome, Slovenian type"/>
</dbReference>
<dbReference type="Orphanet" id="740">
<property type="disease" value="Hutchinson-Gilford progeria syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="54260">
<property type="disease" value="Left ventricular noncompaction"/>
</dbReference>
<dbReference type="Orphanet" id="363618">
<property type="disease" value="LMNA-related cardiocutaneous progeria syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="90153">
<property type="disease" value="Mandibuloacral dysplasia with type A lipodystrophy"/>
</dbReference>
<dbReference type="Orphanet" id="1662">
<property type="disease" value="Restrictive dermopathy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA231"/>
<dbReference type="eggNOG" id="KOG0977">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157244"/>
<dbReference type="HOGENOM" id="CLU_012560_9_1_1"/>
<dbReference type="InParanoid" id="P02545"/>
<dbReference type="KO" id="K12641"/>
<dbReference type="OMA" id="CGQPAEK"/>
<dbReference type="OrthoDB" id="701388at2759"/>
<dbReference type="PhylomeDB" id="P02545"/>
<dbReference type="TreeFam" id="TF101181"/>
<dbReference type="PathwayCommons" id="P02545"/>
<dbReference type="Reactome" id="R-HSA-1221632">
<molecule id="P02545-2"/>
<property type="pathway name" value="Meiotic synapsis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2980766">
<property type="pathway name" value="Nuclear Envelope Breakdown"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2995383">
<property type="pathway name" value="Initiation of Nuclear Envelope (NE) Reformation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-352238">
<molecule id="P02545-1"/>
<property type="pathway name" value="Breakdown of the nuclear lamina"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381038">
<property type="pathway name" value="XBP1(S) activates chaperone genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4419969">
<property type="pathway name" value="Depolymerisation of the Nuclear Lamina"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8862803">
<molecule id="P02545-1"/>
<property type="pathway name" value="Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models"/>
</dbReference>
<dbReference type="SIGNOR" id="P02545"/>
<dbReference type="BioGRID-ORCS" id="4000">
<property type="hits" value="72 hits in 877 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="LMNA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P02545"/>
<dbReference type="GeneWiki" id="LMNA"/>
<dbReference type="GenomeRNAi" id="4000"/>
<dbReference type="Pharos" id="P02545">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P02545"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="P02545">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160789">
<property type="expression patterns" value="Expressed in mucosa of stomach and 251 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P02545">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P02545">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005882">
<property type="term" value="C:intermediate filament"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005638">
<property type="term" value="C:lamin filament"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005635">
<property type="term" value="C:nuclear envelope"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005652">
<property type="term" value="C:nuclear lamina"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0005198">
<property type="term" value="F:structural molecule activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034613">
<property type="term" value="P:cellular protein localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030951">
<property type="term" value="P:establishment or maintenance of microtubule cytoskeleton polarity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0036498">
<property type="term" value="P:IRE1-mediated unfolded protein response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007084">
<property type="term" value="P:mitotic nuclear envelope reassembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007517">
<property type="term" value="P:muscle organ development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903243">
<property type="term" value="P:negative regulation of cardiac muscle hypertrophy in response to stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072201">
<property type="term" value="P:negative regulation of mesenchymal cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090201">
<property type="term" value="P:negative regulation of release of cytochrome c from mitochondria"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006998">
<property type="term" value="P:nuclear envelope organization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0090343">
<property type="term" value="P:positive regulation of cell aging"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1900114">
<property type="term" value="P:positive regulation of histone H3-K9 trimethylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006606">
<property type="term" value="P:protein import into nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034504">
<property type="term" value="P:protein localization to nucleus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030334">
<property type="term" value="P:regulation of cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900180">
<property type="term" value="P:regulation of protein localization to nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031647">
<property type="term" value="P:regulation of protein stability"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032204">
<property type="term" value="P:regulation of telomere maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055015">
<property type="term" value="P:ventricular cardiac muscle cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="DisProt" id="DP00716"/>
<dbReference type="Gene3D" id="1.20.5.1160">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.1260">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR018039">
<property type="entry name" value="IF_conserved"/>
</dbReference>
<dbReference type="InterPro" id="IPR039008">
<property type="entry name" value="IF_rod_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR042180">
<property type="entry name" value="IF_rod_dom_coil1B"/>
</dbReference>
<dbReference type="InterPro" id="IPR001322">
<property type="entry name" value="Lamin_tail_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036415">
<property type="entry name" value="Lamin_tail_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00038">
<property type="entry name" value="Filament"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00932">
<property type="entry name" value="LTD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01391">
<property type="entry name" value="Filament"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF74853">
<property type="entry name" value="SSF74853"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00226">
<property type="entry name" value="IF_ROD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51842">
<property type="entry name" value="IF_ROD_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51841">
<property type="entry name" value="LTD"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0122">Cardiomyopathy</keyword>
<keyword id="KW-0144">Charcot-Marie-Tooth disease</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0912">Congenital muscular dystrophy</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1067">Emery-Dreifuss muscular dystrophy</keyword>
<keyword id="KW-0403">Intermediate filament</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0947">Limb-girdle muscular dystrophy</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0622">Neuropathy</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0636">Prenylation</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Prelamin-A/C" id="PRO_0000398835">
<location>
<begin position="1"/>
<end position="661"/>
</location>
</feature>
<feature type="chain" description="Lamin-A/C" id="PRO_0000063810">
<location>
<begin position="1"/>
<end position="646"/>
</location>
</feature>
<feature type="propeptide" description="Removed in Lamin-A/C form" id="PRO_0000398836">
<location>
<begin position="647"/>
<end position="661"/>
</location>
</feature>
<feature type="propeptide" description="Removed in Prelamin-A/C form and in Lamin-A/C form" id="PRO_0000403442">
<location>
<begin position="662"/>
<end position="664"/>
</location>
</feature>
<feature type="domain" description="IF rod" evidence="29">
<location>
<begin position="31"/>
<end position="387"/>
</location>
</feature>
<feature type="domain" description="LTD" evidence="28">
<location>
<begin position="428"/>
<end position="545"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MLIP" evidence="92">
<location>
<begin position="1"/>
<end position="130"/>
</location>
</feature>
<feature type="region of interest" description="Head">
<location>
<begin position="1"/>
<end position="33"/>
</location>
</feature>
<feature type="region of interest" description="Coil 1A">
<location>
<begin position="34"/>
<end position="70"/>
</location>
</feature>
<feature type="region of interest" description="Linker 1">
<location>
<begin position="71"/>
<end position="80"/>
</location>
</feature>
<feature type="region of interest" description="Coil 1B">
<location>
<begin position="81"/>
<end position="218"/>
</location>
</feature>
<feature type="region of interest" description="Linker 2">
<location>
<begin position="219"/>
<end position="242"/>
</location>
</feature>
<feature type="region of interest" description="Coil 2">
<location>
<begin position="243"/>
<end position="383"/>
</location>
</feature>
<feature type="region of interest" description="Tail">
<location>
<begin position="384"/>
<end position="664"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="27">
<location>
<begin position="417"/>
<end position="422"/>
</location>
</feature>
<feature type="site" description="Heptad change of phase">
<location>
<position position="266"/>
</location>
</feature>
<feature type="site" description="Stutter" evidence="24">
<location>
<position position="325"/>
</location>
</feature>
<feature type="site" description="Heptad change of phase">
<location>
<position position="330"/>
</location>
</feature>
<feature type="site" description="Cleavage; by endoprotease">
<location>
<begin position="646"/>
<end position="647"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="15">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 15 17 18">
<location>
<position position="12"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="18"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8 12 15 17 18">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 15 17 18 107">
<location>
<position position="22"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="25">
<location>
<position position="32"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="25">
<location>
<position position="32"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="51"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="71"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="107"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="14">
<location>
<position position="108"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="123"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="135"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="155"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="25">
<location>
<position position="171"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="25">
<location>
<position position="171"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="25">
<location>
<position position="201"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 17 18">
<location>
<position position="212"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="25">
<location>
<position position="260"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="14">
<location>
<position position="270"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 15">
<location>
<position position="277"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 15 17 18">
<location>
<position position="301"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="307"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="14">
<location>
<position position="311"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 15 16 17 18">
<location>
<position position="390"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 15 16 17">
<location>
<position position="392"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 15 18">
<location>
<position position="395"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="403"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 16 18">
<location>
<position position="404"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="407"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 16 18">
<location>
<position position="414"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="429"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="431"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="14">
<location>
<position position="450"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="25">
<location>
<position position="457"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 15 16 17 18">
<location>
<position position="458"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 17 18">
<location>
<position position="463"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="26">
<location>
<position position="496"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="505"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="26">
<location>
<position position="510"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="533"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="546"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="25">
<location>
<position position="548"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="568"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="571"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18">
<location>
<position position="612"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="613"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="616"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="17">
<location>
<position position="619"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 10 11 12 15 17">
<location>
<position position="628"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 13 15 17">
<location>
<position position="632"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 12 15 16 17 18">
<location>
<position position="636"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 15">
<location>
<position position="652"/>
</location>
</feature>
<feature type="modified residue" description="Cysteine methyl ester" evidence="105 106">
<location>
<position position="661"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-farnesyl cysteine" evidence="105 106">
<location>
<position position="661"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="32"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 22 23">
<location>
<position position="97"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="171"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="201"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="201"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 23">
<location>
<position position="208"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="219"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19 20 21 23">
<location>
<position position="233"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="21 23">
<location>
<position position="260"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="21 23">
<location>
<position position="270"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 22 23">
<location>
<position position="311"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="366"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 21 22 23">
<location>
<position position="378"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 21 23">
<location>
<position position="417"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="20 21 22 23">
<location>
<position position="420"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="23">
<location>
<position position="450"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="470"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="23">
<location>
<position position="486"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="19">
<location>
<position position="597"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="19 23">
<location>
<position position="597"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_053503" evidence="114">
<location>
<begin position="1"/>
<end position="99"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_045977" evidence="108">
<original>METPSQR</original>
<variation>MGNSEGC</variation>
<location>
<begin position="1"/>
<end position="7"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_045978" evidence="108">
<location>
<begin position="8"/>
<end position="119"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_053504" evidence="114">
<original>ARLQLELSKVREEFKELKAR</original>
<variation>MDLEAWDPHLEPDAEAMVDG</variation>
<location>
<begin position="100"/>
<end position="119"/>
</location>
</feature>
<feature type="splice variant" description="In isoform ADelta10." id="VSP_002468" evidence="112">
<location>
<begin position="537"/>
<end position="566"/>
</location>
</feature>
<feature type="splice variant" description="In isoform C." id="VSP_002469" evidence="109 110 111">
<original>GSHCSS</original>
<variation>VSGSRR</variation>
<location>
<begin position="567"/>
<end position="572"/>
</location>
</feature>
<feature type="splice variant" description="In isoform C." id="VSP_002470" evidence="109 110 111">
<location>
<begin position="573"/>
<end position="664"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_053505" evidence="113">
<location>
<begin position="607"/>
<end position="656"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_045979" evidence="108">
<original>M</original>
<variation>IQEMGMRWEVEEGRRKVSLSCLP</variation>
<location>
<position position="664"/>
</location>
</feature>
<feature type="sequence variant" description="In an atypical progeroid patient; diagnosed as Seip syndrome; unknown pathological significance; dbSNP:rs57077886." id="VAR_039745" evidence="64">
<original>T</original>
<variation>I</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD3." id="VAR_076562" evidence="103">
<original>T</original>
<variation>S</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs58327533." id="VAR_039746" evidence="62">
<original>R</original>
<variation>G</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; mis-localized in the nucleus; causes nuclear deformations and LMNB1 redistribution; dbSNP:rs61578124." id="VAR_039747" evidence="40 91">
<original>R</original>
<variation>P</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; dbSNP:rs59914820." id="VAR_039748" evidence="46">
<original>R</original>
<variation>W</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; abnormal nuclear localization in a honeycomb expression pattern in about 11% of cultured skin fibroblasts from heterozygous patients; no effect on protein level." id="VAR_039749" evidence="50 62 69">
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2; autosomal dominant form; dbSNP:rs57966821." id="VAR_039750" evidence="63">
<original>E</original>
<variation>D</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607614." id="VAR_039751" evidence="63">
<original>E</original>
<variation>G</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs56694480." id="VAR_039752" evidence="62">
<original>L</original>
<variation>V</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In MDCL and EDMD2; dbSNP:rs57983345." id="VAR_063588" evidence="80 91">
<original>N</original>
<variation>S</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs60446065." id="VAR_039753" evidence="40">
<original>A</original>
<variation>T</variation>
<location>
<position position="43"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs58436778." id="VAR_009971" evidence="39 91">
<original>Y</original>
<variation>C</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2 and MDCL; dbSNP:rs60695352." id="VAR_009972" evidence="39 80">
<original>R</original>
<variation>P</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs59931416." id="VAR_039754" evidence="40">
<original>R</original>
<variation>S</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In CMDHH; phenotype originally designated as atypical Werner syndrome; dbSNP:rs28928903." id="VAR_017656" evidence="60">
<original>A</original>
<variation>P</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In CMDHH; dbSNP:rs58922911." id="VAR_064055" evidence="77 85">
<original>L</original>
<variation>R</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A and FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs28928900." id="VAR_034706" evidence="32 43 49">
<original>R</original>
<variation>G</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; dbSNP:rs56793579." id="VAR_039755" evidence="46">
<original>R</original>
<variation>G</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs57793737." id="VAR_039756" evidence="50 55 71">
<original>I</original>
<variation>N</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; no effect on protein level; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; dbSNP:rs57793737." id="VAR_009974" evidence="39 69">
<original>I</original>
<variation>S</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2." id="VAR_039757" evidence="62">
<original>E</original>
<variation>G</variation>
<location>
<position position="65"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs28933090." id="VAR_009975" evidence="32 43">
<original>L</original>
<variation>R</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci; dbSNP:rs59040894." id="VAR_039758" evidence="53 89">
<original>R</original>
<variation>L</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs267607560." id="VAR_067257" evidence="95">
<original>L</original>
<variation>F</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs59065411." id="VAR_039759" evidence="45">
<original>K</original>
<variation>E</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci; dbSNP:rs267607568." id="VAR_070174" evidence="89">
<original>R</original>
<variation>P</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2." id="VAR_009976" evidence="39 62">
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with atrial fibrillation; unknown pathological significance; dbSNP:rs267607605." id="VAR_072817" evidence="87">
<original>G</original>
<variation>S</variation>
<location>
<position position="125"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; dbSNP:rs60864230." id="VAR_016913" evidence="54">
<original>R</original>
<variation>L</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs60864230." id="VAR_017657" evidence="40">
<original>R</original>
<variation>P</variation>
<location>
<position position="133"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; might be associated with early and severe strokes; dbSNP:rs267607649." id="VAR_070175" evidence="94">
<original>E</original>
<variation>K</variation>
<location>
<position position="138"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs60652225." id="VAR_039760" evidence="55 71">
<original>L</original>
<variation>P</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; phenotype originally designated as atypical Werner syndrome; dbSNP:rs60652225." id="VAR_017658" evidence="60">
<original>L</original>
<variation>R</variation>
<location>
<position position="140"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; dbSNP:rs58912633." id="VAR_034707" evidence="70">
<original>S</original>
<variation>F</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs61661343." id="VAR_039761" evidence="65">
<original>S</original>
<variation>P</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; atypical; dbSNP:rs60310264." id="VAR_017659" evidence="57">
<original>E</original>
<variation>K</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs58917027." id="VAR_039762" evidence="38 91">
<original>T</original>
<variation>P</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs28933093." id="VAR_017660" evidence="59 95">
<original>E</original>
<variation>K</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dramatically aberrant localization with almost no nuclear rim staining and formation of intranuclear foci; dbSNP:rs267607570." id="VAR_070176" evidence="89">
<original>R</original>
<variation>P</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; found also in a patient with limb-girdle muscular dystrophy; sporadic; dbSNP:rs267607643." id="VAR_064962" evidence="91">
<original>R</original>
<variation>P</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2 and CMD1A; aberrant localization with decreased nuclear rim staining and increased formation of intranuclear foci; dbSNP:rs267607571." id="VAR_039763" evidence="71 89">
<original>R</original>
<variation>Q</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2." id="VAR_064963" evidence="91">
<original>R</original>
<variation>RR</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs59026483." id="VAR_039764" evidence="45 66 73">
<original>R</original>
<variation>W</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dramatically increases the size of intranuclear speckles and reduces their number; this phenotype is only partially reversed by coexpression of the G-192 mutation and wild-type lamin-C; precludes insertion of lamin-C into the nuclear envelope when co-transfected with the G-192 LMNA; G-192 lamin-C expression totally disrupts the SUMO1 pattern; dbSNP:rs57045855." id="VAR_039765" evidence="73">
<original>D</original>
<variation>G</variation>
<location>
<position position="192"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs28933091." id="VAR_009977" evidence="32 43">
<original>N</original>
<variation>K</variation>
<location>
<position position="195"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2." id="VAR_039766" evidence="40">
<original>RLQT</original>
<variation>S</variation>
<location>
<begin position="196"/>
<end position="199"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; decreased sumoylation; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; associated with increased cell death; dbSNP:rs28933092." id="VAR_009978" evidence="32 43 81">
<original>E</original>
<variation>G</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; decreased sumoylation; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; associated with increased cell death; dbSNP:rs61195471." id="VAR_039767" evidence="42 81 89">
<original>E</original>
<variation>K</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607629." id="VAR_064964" evidence="91">
<original>F</original>
<variation>L</variation>
<location>
<position position="206"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level." id="VAR_034708" evidence="37 69">
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dramatically aberrant localization with almost no nuclear rim staining and increased formation of intranuclear foci; dbSNP:rs267607572." id="VAR_070177" evidence="89">
<original>I</original>
<variation>S</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; dbSNP:rs61295588." id="VAR_039768" evidence="52 89">
<original>L</original>
<variation>P</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs58034145." id="VAR_039769" evidence="39">
<original>H</original>
<variation>P</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs28928901." id="VAR_009979" evidence="36">
<original>H</original>
<variation>Y</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD3; dbSNP:rs199474724." id="VAR_067697" evidence="98">
<original>R</original>
<variation>Q</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; dbSNP:rs61214927." id="VAR_039770" evidence="78">
<original>D</original>
<variation>N</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs57207746." id="VAR_039771" evidence="39">
<original>G</original>
<variation>E</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs58850446." id="VAR_039772" evidence="62">
<original>L</original>
<variation>P</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level; dbSNP:rs59332535." id="VAR_009980" evidence="36 39 40 47 55 62 69 71 91">
<original>R</original>
<variation>Q</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In MDCL and EDMD2; mislocalized in the nucleus; causes nuclear deformations and LMNB1 redistribution; dbSNP:rs121912496." id="VAR_063589" evidence="80 91">
<original>R</original>
<variation>W</variation>
<location>
<position position="249"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2." id="VAR_076563" evidence="103">
<original>Y</original>
<variation>C</variation>
<location>
<position position="259"/>
</location>
</feature>
<feature type="sequence variant" description="In CMDA1." id="VAR_039773" evidence="74">
<original>K</original>
<variation>N</variation>
<location>
<position position="260"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2." id="VAR_009981" evidence="38 39 40">
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs57048196." id="VAR_039774" evidence="62">
<original>Y</original>
<variation>C</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607630." id="VAR_064965" evidence="91">
<original>S</original>
<variation>P</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607641." id="VAR_064966" evidence="91">
<original>L</original>
<variation>P</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs61616775." id="VAR_009982" evidence="39 91">
<original>Q</original>
<variation>P</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607633." id="VAR_064967" evidence="91">
<original>S</original>
<variation>P</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In CMT2B1; dbSNP:rs59885338." id="VAR_017661" evidence="44">
<original>R</original>
<variation>C</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; atypical form with late onset; abnormal nuclear morphology with single or multple blebs, lobulation and occasional ringed or donut shaped nuclei; dbSNP:rs79907212." id="VAR_070178" evidence="99">
<original>D</original>
<variation>G</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="sequence variant" description="In MDCL; dbSNP:rs267607596." id="VAR_063590" evidence="80">
<original>L</original>
<variation>P</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs61527854." id="VAR_064968" evidence="91">
<original>S</original>
<variation>P</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs56816490." id="VAR_039775" evidence="45 95">
<original>E</original>
<variation>K</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; no effect on nuclear morphology and lamin A localization; dbSNP:rs267607574." id="VAR_070179" evidence="89">
<original>A</original>
<variation>T</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs58105277." id="VAR_009983" evidence="36 50">
<original>R</original>
<variation>Q</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs61177390." id="VAR_009984" evidence="50">
<original>R</original>
<variation>Q</variation>
<location>
<position position="343"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs58789393." id="VAR_039776" evidence="66">
<original>R</original>
<variation>L</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2." id="VAR_064969" evidence="91">
<location>
<position position="355"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2 and MDCL; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci when transfected in C2C12 myoblasts; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; interacts with itself and with wild-type LMNA and LMNB1; no effect on protein level; dbSNP:rs60458016." id="VAR_009985" evidence="39 40 43 69 80 91">
<original>E</original>
<variation>K</variation>
<location>
<position position="358"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607634." id="VAR_064970" evidence="91">
<original>E</original>
<variation>K</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs59653062." id="VAR_009986" evidence="39 43">
<original>M</original>
<variation>K</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; no obvious effect on nuclear morphology in cultured skin fibroblasts from heterozygous patients; no effect on protein level; dbSNP:rs61672878." id="VAR_016205" evidence="37 53 56 69 71 76">
<original>R</original>
<variation>H</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs61672878." id="VAR_039777" evidence="47 55">
<original>R</original>
<variation>L</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="sequence variant" description="In MDCL; dbSNP:rs121912495." id="VAR_063591" evidence="80">
<original>L</original>
<variation>S</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dramatically aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; distribution of endogenous LMNA, LMNB1 and LMNB2 are altered in cells expressing this mutant; causes an increased loss of endogenous EMD from the nuclear envelope; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs267607545." id="VAR_009987" evidence="39 43 55 91">
<original>R</original>
<variation>K</variation>
<location>
<position position="386"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; no effect on nuclear morphology but restricts lamin A to the cytoplasm; dbSNP:rs267607576." id="VAR_070180" evidence="89">
<original>R</original>
<variation>H</variation>
<location>
<position position="388"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2 and CMD1A; no effect on nuclear morphology and lamin A localization; dbSNP:rs58672172." id="VAR_039778" evidence="78 89">
<original>R</original>
<variation>C</variation>
<location>
<position position="399"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; abnormal nuclear localization in a honeycomb expression pattern in about 22% of cultured skin fibroblasts from heterozygous patients; enhances the interaction with SYNE2; no effect on nuclear localization; no effect on protein level; dbSNP:rs61094188." id="VAR_072818" evidence="50 69 101">
<original>R</original>
<variation>C</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in patients with metabolic syndromes; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2; dbSNP:rs267607647." id="VAR_072819" evidence="93 101">
<original>G</original>
<variation>D</variation>
<location>
<position position="411"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; found in patients with skeletal and cardiac muscular dystrophies; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2; dbSNP:rs766811975." id="VAR_072820" evidence="101">
<original>G</original>
<variation>C</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="Rare variant; found in patients with atrial fibrillation; unknown pathological significance; no effect on nuclear lamin A localization; enhances the interaction with SYNE2; causes nuclear deformations in heat shock experiments; dbSNP:rs267607606." id="VAR_072821" evidence="87 101">
<original>V</original>
<variation>I</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; found in patients with lipodystrophy; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2; dbSNP:rs755686359." id="VAR_072822" evidence="101">
<original>R</original>
<variation>C</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in patient with severe metabolic syndrome; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2; dbSNP:rs267607564." id="VAR_072823" evidence="79 101">
<original>L</original>
<variation>P</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; found in patients with skeletal and cardiac muscular dystrophies; no effect on nuclear lamin A localization; no effect on the interaction with SYNE2." id="VAR_072824" evidence="101">
<original>R</original>
<variation>G</variation>
<location>
<position position="427"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs150840924." id="VAR_039779" evidence="62">
<original>R</original>
<variation>C</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; increase in nuclear blebbing and formation of honeycomb-like structures in the nuclei with no accumulation of prelamin A in skin fibroblasts; causes oligomerization of the C-terminal globular domain of lamins A and C under no-reducing conditions and increases binding affinity for DNA; increases sensitivity to oxidative stress; no significant differences in stability and structure compared with the wild-type; dbSNP:rs62636506." id="VAR_070181" evidence="84">
<original>R</original>
<variation>C</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs58541611." id="VAR_039780" evidence="62">
<original>D</original>
<variation>V</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607637." id="VAR_064971" evidence="91">
<original>G</original>
<variation>D</variation>
<location>
<position position="449"/>
</location>
</feature>
<feature type="sequence variant" description="In MDCL; dbSNP:rs267607598." id="VAR_063592" evidence="80">
<original>R</original>
<variation>P</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; abnormal nuclear localization; forms nuclear foci in about 8% of cultured skin fibroblasts from heterozygous patients; interacts with itself and with wild-type LMNA and LMNB1; no effect on protein level; dbSNP:rs58932704." id="VAR_009988" evidence="30 36 39 40 43 62 69 91">
<original>R</original>
<variation>W</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607638." id="VAR_064972" evidence="91">
<original>L</original>
<variation>P</variation>
<location>
<position position="454"/>
</location>
</feature>
<feature type="sequence variant" description="In MDCL; dbSNP:rs267607597." id="VAR_063593" evidence="80">
<original>R</original>
<variation>P</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="sequence variant" description="In MDCL; dbSNP:rs267607599." id="VAR_063594" evidence="80">
<original>N</original>
<variation>D</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; mislocalized in the nucleus; does not alter nuclear size or shape; dbSNP:rs60992550." id="VAR_039781" evidence="40 91">
<original>N</original>
<variation>I</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs61235244." id="VAR_039782" evidence="39">
<original>N</original>
<variation>K</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607642." id="VAR_064973" evidence="91">
<original>D</original>
<variation>Y</variation>
<location>
<position position="461"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; dbSNP:rs61282106." id="VAR_009989" evidence="35">
<original>G</original>
<variation>D</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs267607639." id="VAR_064974" evidence="91">
<original>W</original>
<variation>R</variation>
<location>
<position position="467"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs57394692." id="VAR_009990" evidence="36">
<original>I</original>
<variation>T</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; dbSNP:rs28928902." id="VAR_017662" evidence="58">
<original>R</original>
<variation>C</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; no effect on nuclear morphology and lamin A localization; dbSNP:rs267607578." id="VAR_070182" evidence="89">
<original>R</original>
<variation>H</variation>
<location>
<position position="471"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs57747780." id="VAR_039783" evidence="41">
<original>Y</original>
<variation>H</variation>
<location>
<position position="481"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; abnormal nuclear localization in a honeycomb expression pattern in about 10% of cultured skin fibroblasts from heterozygous patients; no effect on protein level; dbSNP:rs11575937." id="VAR_009991" evidence="34 69">
<original>R</original>
<variation>L</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs11575937." id="VAR_009992" evidence="33 35 43">
<original>R</original>
<variation>Q</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; decreases binding affinity for DNA; increases sensitivity to oxidative stress; dbSNP:rs57920071." id="VAR_009993" evidence="34 35 43 84">
<original>R</original>
<variation>W</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs59981161." id="VAR_009994" evidence="43">
<original>K</original>
<variation>N</variation>
<location>
<position position="486"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; found in patient with atrial fibrillation; dbSNP:rs267607607." id="VAR_072825" evidence="87">
<original>T</original>
<variation>P</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2." id="VAR_071968" evidence="102">
<original>K</original>
<variation>E</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs58362413." id="VAR_039784" evidence="39 43">
<original>W</original>
<variation>S</variation>
<location>
<position position="520"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; dbSNP:rs201583907." id="VAR_067258" evidence="95">
<original>G</original>
<variation>R</variation>
<location>
<position position="523"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; dbSNP:rs57318642." id="VAR_017663" evidence="58">
<original>R</original>
<variation>C</variation>
<location>
<position position="527"/>
</location>
</feature>
<feature type="sequence variant" description="In MADA; dbSNP:rs57520892." id="VAR_018727" evidence="48">
<original>R</original>
<variation>H</variation>
<location>
<position position="527"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2 and FPLD2; interacts with itself and with wild-type LMNA and LMNB1; reduced binding to SUN1; abnormal nuclear localization; forms nuclear foci in about 13% of cultured skin fibroblasts from heterozygous patients; no effect on protein level; dbSNP:rs57520892." id="VAR_009995" evidence="30 36 39 40 43 49 55 69 71 88 91">
<original>R</original>
<variation>P</variation>
<location>
<position position="527"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; interacts with itself and with wild-type LMNA and LMNB1; no decrease in the stability compared with wild-type; dbSNP:rs57629361." id="VAR_009996" evidence="36 39 43 91">
<original>T</original>
<variation>K</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs57629361." id="VAR_039785" evidence="62 91">
<original>T</original>
<variation>R</variation>
<location>
<position position="528"/>
</location>
</feature>
<feature type="sequence variant" description="In MADA; dbSNP:rs60580541." id="VAR_034709" evidence="72">
<original>A</original>
<variation>V</variation>
<location>
<position position="529"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; interacts with itself and with wild-type LMNA and LMNB1; reduced binding to SUN1; no decrease in the stability compared with wild-type; dbSNP:rs60934003." id="VAR_009997" evidence="30 43 88">
<original>L</original>
<variation>P</variation>
<location>
<position position="530"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A; grossly abnormal nuclear shape with the nuclear envelope producing prominent lobules in about 10% of cultured skin fibroblasts from heterozygous patients; dbSNP:rs56984562." id="VAR_039786" evidence="61 69 83">
<original>R</original>
<variation>C</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs61444459." id="VAR_039787" evidence="62">
<original>R</original>
<variation>H</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; mis-localized in the nucleus; does not alter nuclear size or shape; dbSNP:rs61444459." id="VAR_064975" evidence="91">
<original>R</original>
<variation>P</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2 and CMD1A; modest and non-specific nuclear membrane alterations; the phenotype is entirely reversed by coexpression of the S-541 mutation and wild-type lamin-C; dbSNP:rs56984562." id="VAR_039788" evidence="73 91">
<original>R</original>
<variation>S</variation>
<location>
<position position="541"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; dbSNP:rs56673169." id="VAR_034710" evidence="67">
<original>K</original>
<variation>N</variation>
<location>
<position position="542"/>
</location>
</feature>
<feature type="sequence variant" description="In CMD1A, FPLD2 and MADA; dbSNP:rs60890628." id="VAR_039789" evidence="53 75 78">
<original>S</original>
<variation>L</variation>
<location>
<position position="573"/>
</location>
</feature>
<feature type="sequence variant" description="In an atypical progeroid patient; diagnosed as Werner syndrome; dbSNP:rs61224243." id="VAR_039790" evidence="64">
<original>E</original>
<variation>V</variation>
<location>
<position position="578"/>
</location>
</feature>
<feature type="sequence variant" description="In FPLD2; dbSNP:rs57830985." id="VAR_009998" evidence="35">
<original>R</original>
<variation>H</variation>
<location>
<position position="582"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs60662302." id="VAR_064976" evidence="91">
<original>G</original>
<variation>S</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS; reduced binding to SUN1; may affect splicing by activating a cryptic splice donor site; dbSNP:rs61064130." id="VAR_017664" evidence="57 58 88">
<original>G</original>
<variation>S</variation>
<location>
<position position="608"/>
</location>
</feature>
<feature type="sequence variant" description="In EDMD2; dbSNP:rs13768." id="VAR_039791" evidence="40">
<original>R</original>
<variation>H</variation>
<location>
<position position="624"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a patient with metabolic syndrome; dbSNP:rs267607648." id="VAR_072826" evidence="93">
<original>G</original>
<variation>D</variation>
<location>
<position position="631"/>
</location>
</feature>
<feature type="sequence variant" description="In HGPS and EDMD2; partially inhibits tail cleavage; dbSNP:rs142000963." id="VAR_039792" evidence="64 91 97">
<original>R</original>
<variation>C</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased sumoylation; aberrant localization with decreased nuclear rim staining and formation of intranuclear foci; associated with increased cell death." evidence="81">
<original>K</original>
<variation>L</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect tail cleavage." evidence="97">
<original>R</original>
<variation>A</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="mutagenesis site" description="Completely inhibits tail cleavage." evidence="97">
<original>L</original>
<variation>R</variation>
<location>
<position position="647"/>
</location>
</feature>
<feature type="mutagenesis site" description="Completely inhibits tail cleavage." evidence="97">
<original>L</original>
<variation>A</variation>
<location>
<position position="648"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially inhibits tail cleavage." evidence="97">
<original>N</original>
<variation>A</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with NARF. Abolishes farnesylation." evidence="31 97">
<original>C</original>
<variation>S</variation>
<location>
<position position="661"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG58344." ref="5" evidence="114">
<original>E</original>
<variation>K</variation>
<location>
<position position="340"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="28"/>
<end position="44"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="65"/>
<end position="218"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="252"/>
<end position="278"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="316"/>
<end position="384"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="430"/>
<end position="436"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="438"/>
<end position="445"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="449"/>
<end position="456"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="458"/>
<end position="460"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="464"/>
<end position="466"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="468"/>
<end position="473"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="479"/>
<end position="482"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="494"/>
<end position="499"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="500"/>
<end position="502"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="508"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="511"/>
<end position="514"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="526"/>
<end position="531"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="537"/>
<end position="543"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG58344." ref="5" evidence="114">
<original>G</original>
<variation>R</variation>
<location sequence="P02545-4">
<position position="556"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IFR"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IVT"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1X8Y"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GEF"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6GHD"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6JLB"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6SNZ"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000250"/>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P48678"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P48679"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000255"/>
<evidence key="28" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01187"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU01188"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10080180"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10514485"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10580070"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10587585"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10655060"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10739751"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10739764"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10814726"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10908904"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10939567"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11503164"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11525883"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11561226"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11792809"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11799477"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11897440"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12015247"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12032588"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12075506"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12196663"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12467752"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12475961"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12486434"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12628721"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12629077"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12649505"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12673789"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12714972"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12768443"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12920062"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12927431"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14675861"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14684700"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14985400"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15060110"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15140538"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15219508"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15286156"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15317753"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15372542"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15622532"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15744034"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15998779"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16061563"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16156025"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16278265"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17136397"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17150192"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17250669"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17711925"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18551513"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18606848"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18611980"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19167105"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19220582"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19283854"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19323649"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19427440"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19933576"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20160190"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20458013"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20848652"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21498514"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21724554"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21791255"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21846512"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21949239"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22355414"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22431096"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23666920"/>
</source>
</evidence>
<evidence key="100" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23695662"/>
</source>
</evidence>
<evidence key="101" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23977161"/>
</source>
</evidence>
<evidence key="102" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24485160"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27234031"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29599122"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8175923"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9030603"/>
</source>
</evidence>
<evidence key="107" type="ECO:0000269">
<source ref="9"/>
</evidence>
<evidence key="108" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="109" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="110" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3453101"/>
</source>
</evidence>
<evidence key="111" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3462705"/>
</source>
</evidence>
<evidence key="112" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8621584"/>
</source>
</evidence>
<evidence key="113" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="114" type="ECO:0000305"/>
<sequence length="664" mass="74139" checksum="E0855F7699F0318B" modified="1987-03-20" version="1" precursor="true">METPSQRRATRSGAQASSTPLSPTRITRLQEKEDLQELNDRLAVYIDRVRSLETENAGLRLRITESEEVVSREVSGIKAAYEAELGDARKTLDSVAKERARLQLELSKVREEFKELKARNTKKEGDLIAAQARLKDLEALLNSKEAALSTALSEKRTLEGELHDLRGQVAKLEAALGEAKKQLQDEMLRRVDAENRLQTMKEELDFQKNIYSEELRETKRRHETRLVEIDNGKQREFESRLADALQELRAQHEDQVEQYKKELEKTYSAKLDNARQSAERNSNLVGAAHEELQQSRIRIDSLSAQLSQLQKQLAAKEAKLRDLEDSLARERDTSRRLLAEKEREMAEMRARMQQQLDEYQELLDIKLALDMEIHAYRKLLEGEEERLRLSPSPTSQRSRGRASSHSSQTQGGGSVTKKRKLESTESRSSFSQHARTSGRVAVEEVDEEGKFVRLRNKSNEDQSMGNWQIKRQNGDDPLLTYRFPPKFTLKAGQVVTIWAAGAGATHSPPTDLVWKAQNTWGCGNSLRTALINSTGEEVAMRKLVRSVTVVEDDEDEDGDDLLHHHHGSHCSSSGDPAEYNLRSRTVLCGTCGQPADKASASGSGAQVGGPISSGSSASSVTVTRSYRSVGGSGGGSFGDNLVTRSYLLGNSSPRTQSPQNCSIM</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

